rfhg_81700.1

Basic information about the TSS

---

TSS ID: rfhg_81700.1 Species: human Chr: chr6		Start: 34237187 End: 34237187 Strand: +
Source datasets	DRA013844
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3834156,EH38E2461385)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000478214.1:17 GeneID: 3159 HGNC/MGI_ID: HGNC:5010 UniProt_ID: Nearer transcript ids and distances: M23614:-35 M23615:-35 AF176039:114 BC067083:-242 BC071863:-244 BC071864:-262 BC004924:-267 BC008963:-267 BC008832:-267 BC063434:-273 AK308245:-284 X14957:-296 X14958:-296 AK301434:-313 ENST00000674029.1:-314 ENST00000447654.5:-314 ENST00000347617.10:-314 ENST00000401473.7:-314 ENST00000311487.9:-314 NM_001319081.2:-314 NM_001319077.2:-314 NM_001319079.2:-314 NM_145903.3:-314 NM_001319078.2:-314 NM_002131.4:-314 NM_001319080.2:-314 NM_145899.3:-314 NM_001319082.2:-314 NM_145902.3:-314 NM_145901.3:-314 AK096863:-314 M23616:-314 M23617:-314 LQ270834:-314 LQ270836:-314 LF213809:-354 MA449386:-354 LQ270830:-387 LQ270832:-387 LQ270838:-387 M23619:432 view more...

Gene_name: high mobility group AT-hook 1 Gene_symbol: HMGA1 Gene_synonyms: Gene_source: HGNC:5010

TATA-Box annotation

---

Distance to TSS:	314
Nearest PromoterID:	NM_001319077
Entrez ID:	3159
Nearest Unigene:	Hs.518805
Nearest Refseq:	NM_002131
Nearest Ensembl:	ENSG00000137309
Gene Name:	high mobility group AT-hook 1
Gene Alias:	HMG-R|HMGA1A|HMGIY
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	1.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@HMGA1 p2@HMGA1 p3@HMGA1 p4@HMGA1 p5@HMGA1 p9@HMGA1
Sample		p1@HMGA1	p2@HMGA1	p3@HMGA1	p4@HMGA1	p5@HMGA1	p9@HMGA1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	45.00	134.02	37.01	20.65	4.09	1.17
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	44.51	131.91	40.06	14.36	4.86	1.42
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	49.38	146.22	42.63	17.94	3.28	2.12
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	42.41	129.53	38.26	14.97	2.70	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	45.44	125.53	41.17	21.15	2.47	1.35
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	53.10	143.81	49.23	17.06	3.10	0.97
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	86.94	158.84	81.92	23.97	1.96	1.09
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	64.19	154.29	78.96	27.37	1.94	2.18
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	57.28	140.84	78.22	25.22	2.35	1.28
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	48.69	138.53	62.02	16.81	0.58	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	37.19	120.06	48.51	12.53	2.43	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	36.18	120.34	53.66	11.38	1.63	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	237.11	143.62	19.34	5.64	10.48	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	254.24	129.75	19.70	5.11	10.22	2.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	232.51	124.49	17.34	5.71	11.64	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	251.99	139.83	17.10	6.79	9.05	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	245.27	135.85	18.78	5.46	8.74	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	232.42	147.64	16.03	7.17	9.28	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	198.33	137.55	15.99	4.27	7.46	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	243.56	121.11	19.26	5.87	9.93	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	262.63	129.24	17.64	6.01	9.76	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	266.53	125.84	19.16	3.97	12.26	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	244.94	135.33	15.77	3.75	8.27	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	230.05	124.25	17.71	5.82	6.31	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	229.09	137.77	15.74	4.90	9.80	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	219.66	146.55	18.67	5.38	9.81	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	187.37	153.85	21.98	4.95	10.99	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	263.34	157.25	20.98	6.37	14.85	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	216.12	120.82	16.48	5.81	6.78	1.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	229.65	119.98	18.10	5.25	8.87	3.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	190.08	111.16	19.68	4.81	6.49	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	190.69	111.17	14.65	3.91	8.40	2.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	211.66	128.52	21.95	4.85	7.17	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	242.63	162.30	19.46	6.93	8.41	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	225.70	127.34	20.01	5.80	8.98	2.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	227.46	121.49	18.40	5.56	8.43	1.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	235.45	126.72	19.21	5.72	7.36	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	222.24	142.45	19.34	5.64	7.66	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	223.65	138.02	17.83	6.21	11.34	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	182.69	117.87	15.12	6.00	5.04	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	202.32	119.51	17.41	3.53	8.00	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	197.78	135.12	18.01	6.59	6.88	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	179.89	113.46	14.76	6.12	9.91	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	192.66	117.13	15.38	6.47	9.79	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	192.74	115.24	15.86	4.62	7.63	2.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	180.77	117.25	16.05	4.89	5.12	1.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	169.37	121.39	15.83	5.76	8.88	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	178.53	106.70	17.29	6.26	6.86	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	189.34	124.71	16.52	5.03	10.29	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	175.51	114.44	13.95	5.66	5.46	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	139.78	117.44	14.35	4.30	5.33	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	164.11	138.98	15.34	7.12	6.45	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	153.91	307.83	27.98	0.00	0.00	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	162.53	144.78	21.65	7.10	7.45	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	149.12	134.87	22.87	8.28	5.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	112.42	178.69	12.58	10.07	4.19	5.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	90.01	123.08	16.53	4.59	3.67	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	176.64	145.85	13.94	5.51	4.54	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	164.12	135.53	17.99	6.10	5.46	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	108.76	134.53	18.55	5.34	5.97	2.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	166.39	132.55	23.27	12.69	9.17	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	146.37	131.79	29.16	12.34	8.97	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	77.23	142.51	19.11	8.76	3.98	3.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	91.74	117.22	14.95	10.53	4.76	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	166.68	152.71	27.62	13.32	3.90	2.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	125.31	116.08	22.72	9.58	5.32	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	161.64	96.98	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	94.77	236.92	39.49	15.79	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	89.22	118.47	16.09	5.36	5.36	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	76.86	109.59	14.88	9.92	2.48	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	102.27	116.81	15.48	8.44	4.22	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	69.22	119.56	13.25	3.97	5.30	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	94.97	154.67	17.63	9.59	6.81	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	113.43	135.44	17.12	4.28	7.64	2.45
Adipocyte - breast, donor1	11376-118A8	13.78	17.74	3.17	2.38	0.48	0.16
Adipocyte - breast, donor2	11327-117E4	18.77	32.41	4.33	1.28	0.48	0.48
Adipocyte - omental, donor1	11473-119C6	9.67	18.70	1.78	1.15	1.02	0.00
Adipocyte - omental, donor2	11474-119C7	8.22	17.19	5.98	3.74	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	2.34	12.06	2.01	0.67	0.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	3.19	17.23	1.28	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	15.39	30.79	3.30	1.10	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	237.10	123.75	278.20	34.78	3.61	1.81
Adipocyte - subcutaneous, donor3	11408-118E4	13.38	104.44	3.82	0.52	0.52	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	60.43	44.39	2.93	4.89	1.17	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	4.12	19.30	1.80	3.86	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	35.68	52.69	5.30	5.02	2.51	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	21.16	61.13	4.11	3.53	2.35	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	24.61	38.61	2.33	5.71	1.85	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	8.71	25.50	1.61	8.71	0.65	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	12.80	46.92	1.60	3.73	1.60	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	20.59	43.40	3.34	2.23	1.67	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	10.40	22.87	1.25	3.33	1.25	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	7.03	12.31	1.51	5.27	0.25	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	15.71	40.25	3.27	3.93	1.64	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	8.22	20.10	2.44	2.74	1.22	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	1004.43	384.31	279.56	17.46	9.28	3.09
Alveolar Epithelial Cells, donor2	11590-120G6	1064.63	414.16	473.69	32.27	3.23	7.89
Alveolar Epithelial Cells, donor3	11671-122G6	934.45	354.61	121.00	7.19	0.00	9.58
Amniotic Epithelial Cells, donor1	11533-120A3	225.24	225.60	30.04	19.25	5.40	1.44
Amniotic Epithelial Cells, donor2	11613-122A2	115.47	240.98	6.69	10.04	8.37	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	175.86	211.41	23.01	6.37	4.11	1.03
Anulus Pulposus Cell, donor1	11248-116E6	699.71	144.98	213.40	16.82	7.09	1.03
Anulus Pulposus Cell, donor2	11463-119B5	256.42	92.33	110.45	9.31	8.57	1.96
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	150.06	102.89	80.87	18.87	8.09	4.04
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	196.67	138.49	106.80	21.71	12.59	3.04
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	166.94	126.27	89.89	10.70	12.84	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	156.04	114.19	86.39	16.44	7.77	3.59
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	164.40	123.94	104.97	15.18	16.44	8.85
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	183.50	132.67	111.55	13.20	10.56	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	159.84	115.98	86.09	16.57	12.35	3.90
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	187.87	133.98	97.57	18.45	16.02	2.43
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	207.86	117.59	106.90	17.22	3.56	1.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	186.44	106.59	90.02	19.96	9.79	6.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	173.44	116.83	96.51	24.67	14.51	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	131.65	109.08	80.24	20.06	7.52	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	254.35	118.61	114.49	15.98	8.90	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	200.63	158.32	101.00	20.47	10.92	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	156.67	80.22	75.40	9.50	5.88	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	168.77	117.34	100.73	16.61	10.18	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	227.29	114.12	95.03	15.68	9.45	1.89
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	230.67	143.00	113.06	14.70	10.42	2.14
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	153.15	109.25	79.01	9.75	6.83	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	225.90	106.15	95.37	14.10	12.27	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	140.48	121.27	79.25	12.01	9.61	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	187.63	169.93	138.07	10.62	7.08	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	272.05	139.11	106.86	17.84	13.89	1.72
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	109.07	197.16	100.68	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	147.08	138.35	74.76	17.48	11.65	4.37
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	244.75	146.85	105.87	19.73	10.25	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	173.23	141.73	79.95	16.96	9.69	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	124.27	117.43	62.13	13.11	9.69	2.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	230.24	142.16	94.06	13.04	10.69	1.50
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	190.73	118.98	84.91	10.32	6.97	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	169.38	120.12	79.30	17.83	12.20	2.35
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	265.28	137.62	114.79	19.94	10.29	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	182.64	100.60	92.75	14.98	4.99	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	150.33	126.93	91.84	16.38	12.87	2.34
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	227.31	131.57	108.39	18.97	7.53	2.41
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	177.01	134.24	92.66	15.44	10.69	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	188.17	115.44	96.12	16.78	9.15	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	247.56	123.52	119.70	17.32	12.73	3.31
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	170.28	118.81	95.31	8.90	2.54	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	209.29	119.53	88.90	15.10	10.79	3.45
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	211.26	97.80	96.11	13.76	10.58	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	174.28	95.11	90.76	14.79	7.25	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	181.39	160.61	117.15	24.56	10.39	3.78
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	243.10	115.95	107.14	14.24	9.83	1.19
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	152.88	157.51	118.13	20.85	4.63	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	183.79	120.42	107.74	12.68	6.34	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	185.47	122.00	89.41	17.58	9.65	1.50
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	157.03	155.83	80.02	10.83	11.43	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	139.96	105.70	69.98	10.21	9.48	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	237.70	126.43	102.99	16.78	8.05	2.07
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	204.02	107.11	71.41	10.20	7.65	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	128.39	75.00	83.39	13.47	8.64	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	259.29	143.89	100.54	15.69	10.53	1.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	210.22	119.95	88.13	15.61	7.34	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	149.62	128.11	62.62	16.25	7.65	3.35
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	193.80	125.73	72.07	14.41	9.31	1.33
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	143.43	128.17	73.24	16.78	3.05	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	133.49	109.12	57.60	15.51	6.65	2.22
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	213.16	120.48	69.38	15.36	8.47	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	150.83	119.21	76.32	9.81	5.82	0.36
Astrocyte - cerebellum, donor1	11500-119F6	468.67	313.30	323.62	59.81	7.74	2.46
Astrocyte - cerebellum, donor2	11580-120F5	585.71	262.73	574.41	51.69	9.07	7.87
Astrocyte - cerebellum, donor3	11661-122F5	95.64	170.31	14.89	9.23	1.47	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	216.82	173.94	24.40	13.94	10.11	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	728.95	283.75	280.19	30.41	8.09	3.24
Astrocyte - cerebral cortex, donor3	11392-118C6	200.02	170.34	49.52	20.14	11.93	1.79
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	427.55	555.88	129.14	246.69	3.10	4.93
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	525.31	559.26	178.03	267.48	4.13	3.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	469.87	539.17	153.85	244.55	2.84	2.84
Basophils, donor1	12241-129G9	13.34	87.09	8.11	27.20	0.52	0.00
Basophils, donor2	12242-129H1	15.87	117.98	8.30	17.68	1.08	0.00
Basophils, donor3	12243-129H2	31.46	87.46	11.17	36.31	0.29	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	166.88	258.51	14.01	10.56	7.11	1.51
Bronchial Epithelial Cell, donor2	11591-120G7	437.98	484.16	56.69	24.23	9.14	4.11
Bronchial Epithelial Cell, donor3	11672-122G7	71.74	301.29	14.35	14.35	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	402.95	333.28	63.39	30.13	8.79	1.88
Bronchial Epithelial Cell, donor5	11457-119A8	488.89	347.28	80.89	25.79	2.70	2.70
Bronchial Epithelial Cell, donor6	11461-119B3	591.16	382.05	95.80	19.80	5.30	5.07
Bronchial Epithelial Cell, donor7	11769-123I5	226.19	211.98	13.14	6.48	6.66	1.44
Burkitt's lymphoma cell line:DAUDI	10422-106C8	583.09	420.77	218.99	89.86	13.29	1.44
Burkitt's lymphoma cell line:RAJI	10476-106I8	272.26	350.52	143.93	68.47	7.45	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	131.75	330.01	14.71	36.13	5.44	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	103.42	444.70	10.34	10.34	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	20.29	68.19	14.65	31.56	2.82	0.56
CD14+ Monocytes, donor2	11305-117B9	25.43	139.76	14.11	36.19	0.74	0.93
CD14+ Monocytes, donor3	11381-118B4	20.86	77.94	7.46	20.86	0.88	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	6.79	36.23	2.83	17.83	0.85	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	8.72	47.38	3.79	18.20	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	6.57	42.74	1.97	20.71	0.99	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	77.19	138.91	44.23	49.00	0.14	1.16
CD14+ monocytes - mock treated, donor2	11873-125C1	108.93	165.96	64.57	63.67	0.30	1.51
CD14+ monocytes - mock treated, donor3	11883-125D2	102.57	150.43	66.33	85.99	0.47	1.18
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	87.21	127.22	40.51	33.81	0.00	1.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	118.96	147.39	69.00	48.30	0.83	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	106.61	120.74	64.96	51.82	0.50	0.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	94.57	92.42	30.15	16.64	0.59	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	77.81	104.51	40.06	28.13	0.18	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	72.47	103.59	41.57	26.99	0.22	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	54.79	85.22	24.82	13.35	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	50.69	126.73	31.68	35.38	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	58.80	103.17	35.50	29.95	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	107.99	137.74	46.86	43.14	0.45	0.89
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	128.91	141.68	81.62	47.69	0.80	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	93.07	107.22	45.60	41.43	0.62	1.04
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	123.54	126.75	52.85	30.66	0.23	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	98.62	165.13	63.79	49.54	0.68	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	94.71	103.44	52.38	41.46	0.44	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	24.21	91.19	13.72	18.02	0.27	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	63.68	147.77	39.43	39.95	0.87	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	44.61	110.68	31.98	46.29	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	79.00	106.18	36.74	27.56	0.37	0.73
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	108.85	127.87	62.70	39.10	0.35	1.41
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	123.72	138.64	67.56	43.43	0.44	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	88.93	86.84	34.00	17.96	0.35	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	77.31	130.09	41.26	32.34	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	107.99	126.96	48.93	38.37	0.22	1.08
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	48.73	115.48	18.43	18.43	0.41	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	68.38	156.93	49.14	31.99	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	66.58	100.45	32.01	25.75	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	2.18	51.66	0.44	5.01	0.22	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	4.39	50.59	0.23	9.01	0.69	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	3.25	38.56	0.43	7.58	0.43	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	2.96	81.91	1.09	9.34	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	3.32	69.51	0.52	9.08	0.00	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	3.57	108.81	0.45	16.28	0.22	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	1.53	18.88	0.00	3.06	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	1.76	34.47	0.00	5.27	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	1.89	31.16	0.00	6.32	0.21	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	4.06	65.03	8.13	20.32	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	21.02	65.09	4.75	14.92	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	15.53	84.92	2.07	13.46	3.11	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	23.45	62.37	6.40	13.33	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	20.91	112.57	4.82	17.69	1.61	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	11.23	65.28	0.70	18.95	1.40	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	18.04	80.00	3.92	16.47	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	14.50	60.64	3.95	14.50	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	26.30	104.38	6.58	16.44	1.64	0.00
CD19+ B Cells, donor2	11624-122B4	18.86	116.07	10.16	28.29	1.45	0.00
CD19+ B Cells, donor3	11705-123B4	14.64	108.54	6.06	14.14	1.01	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	174.55	324.86	6.06	3.23	4.44	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	93.88	217.72	3.20	5.59	2.40	0.00
CD34+ Progenitors, donor1	11545-120B6	22.09	150.61	1.00	4.02	4.02	1.00
CD34+ Progenitors, donor2	11625-122B5	53.93	251.13	6.74	17.98	2.81	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	202.53	270.54	13.53	36.45	8.64	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	190.31	350.40	12.18	37.66	8.12	0.45
CD4+ T Cells, donor1	11225-116C1	32.85	164.60	3.93	1.79	4.28	0.00
CD4+ T Cells, donor2	11306-117C1	33.07	222.29	6.12	2.45	1.84	1.84
CD4+ T Cells, donor3	11382-118B5	21.65	170.19	4.88	1.83	3.66	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	16.34	115.62	3.83	1.28	7.15	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	21.11	134.98	4.04	1.80	4.49	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	17.54	133.38	2.01	0.57	4.60	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	13.75	135.12	1.42	1.90	4.27	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	11.24	120.10	2.81	0.70	7.02	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	19.78	154.92	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	18.64	134.83	2.46	2.31	2.60	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	31.86	119.98	4.58	1.02	4.24	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	32.72	95.11	3.71	1.61	3.22	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	8.52	70.83	3.14	0.90	0.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	11.88	90.49	1.05	0.70	1.40	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	13.64	137.27	2.20	0.88	0.88	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	22.35	157.69	2.53	0.84	5.90	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	32.83	136.71	4.36	2.70	5.61	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	30.41	139.33	3.34	3.01	6.01	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	22.03	241.21	2.99	0.54	10.06	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	13.40	215.99	1.61	0.54	10.18	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	17.93	179.32	0.00	0.00	7.17	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	47.10	183.76	3.34	4.08	5.01	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	32.49	122.17	3.03	1.30	3.90	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	32.99	141.85	3.36	2.94	5.67	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	8.60	101.63	2.02	0.51	5.56	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	11.26	109.18	3.03	0.00	5.63	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	21.35	188.27	3.49	1.31	5.23	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	26.72	153.90	2.47	1.48	6.43	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	20.31	91.40	0.92	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	8.37	103.29	2.79	1.40	2.79	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	15.23	160.34	3.05	2.49	4.98	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	16.93	182.57	4.17	1.23	5.15	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	21.56	158.62	4.62	0.00	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	28.65	169.75	3.94	1.07	2.51	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	15.23	112.18	2.77	0.00	2.77	0.00
CD8+ T Cells, donor1	11226-116C2	11.79	96.91	3.60	4.26	3.27	0.00
CD8+ T Cells, donor2	11307-117C2	17.65	121.26	5.26	8.26	1.50	0.00
CD8+ T Cells, donor3	11383-118B6	22.98	123.72	4.54	5.30	2.52	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	24.09	69.96	4.82	15.60	2.52	1.15
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	22.29	77.64	6.95	13.90	0.72	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	35.02	77.43	8.48	12.04	1.64	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	31.22	89.46	11.71	21.01	1.80	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	22.56	64.32	5.04	15.84	1.68	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	23.88	87.09	6.59	19.56	2.50	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	28.03	80.40	9.13	28.68	2.39	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	28.69	73.70	9.21	26.85	1.05	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	29.55	89.82	7.97	25.80	1.64	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	27.77	80.30	7.85	33.21	3.02	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	32.83	71.46	8.42	28.47	1.74	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	29.84	77.00	12.79	35.17	2.93	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	24.08	58.22	10.07	14.45	1.31	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	25.05	65.13	9.11	20.49	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	16.41	61.91	11.19	17.16	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	21.61	83.20	6.12	20.53	1.80	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	21.87	75.38	8.92	21.00	0.86	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	31.35	75.19	10.84	17.68	2.36	1.18
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	37.39	72.89	12.99	38.35	2.22	1.90
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	30.14	72.58	13.23	34.14	1.54	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	31.10	71.81	14.43	31.10	1.28	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	28.68	69.23	11.47	28.68	2.29	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	27.19	50.45	8.67	26.80	1.58	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	20.42	65.81	7.56	9.83	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	16.86	45.77	4.82	8.03	4.82	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	23.78	45.46	7.69	4.20	2.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	28.05	62.11	3.01	14.02	2.00	0.00
Cardiac Myocyte, donor1	11525-119I4	21.93	20.11	0.00	3.66	5.48	0.00
Cardiac Myocyte, donor2	11605-120I3	200.11	148.72	33.60	8.40	7.41	1.48
Cardiac Myocyte, donor3	11686-122I3	68.72	70.93	11.89	2.63	3.68	0.00
Chondrocyte - de diff, donor1	11261-116G1	24.61	36.40	16.29	4.85	1.73	0.00
Chondrocyte - de diff, donor2	11338-117F6	25.59	72.14	8.17	1.78	1.42	0.36
Chondrocyte - de diff, donor3	11410-118E6	21.50	43.01	13.20	1.93	1.48	0.23
Chondrocyte - re diff, donor2	11339-117F7	44.76	84.15	14.32	13.43	1.79	0.00
Chondrocyte - re diff, donor3	11411-118E7	19.01	42.46	13.75	1.62	0.81	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	519.63	265.78	79.76	19.39	5.28	1.26
Ciliary Epithelial Cells, donor2	11323-117D9	370.88	194.95	86.79	16.89	3.63	2.35
Ciliary Epithelial Cells, donor3	11399-118D4	425.41	176.73	76.37	14.69	3.27	2.30
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	35.49	72.08	6.14	8.25	4.49	0.37
Corneal Epithelial Cells, donor1	11526-119I5	493.82	395.45	59.50	22.84	12.08	0.88
Corneal Epithelial Cells, donor2	11606-120I4	84.18	241.17	18.20	10.24	6.83	1.14
Corneal Epithelial Cells, donor3	11687-122I4	388.30	257.42	43.46	18.41	5.62	2.05
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	8.92	35.17	5.78	59.27	0.83	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	9.15	23.97	3.15	55.51	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	48.31	0.00	34.51	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	8.32	35.31	3.78	48.81	0.86	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	28.01	75.50	8.20	82.34	5.12	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	17.63	88.14	2.61	62.68	7.18	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	12.58	73.08	5.32	79.85	6.29	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	925.90	157.10	1159.71	45.19	13.68	2.17
Endothelial Cells - Aortic, donor1	11263-116G3	492.89	136.72	755.77	42.25	11.15	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	619.33	165.72	574.08	35.35	5.66	2.26
Endothelial Cells - Aortic, donor3	11412-118E8	600.39	158.45	1145.74	35.39	2.75	0.79
Endothelial Cells - Artery, donor1	11264-116G4	548.01	145.73	522.70	26.18	4.65	1.45
Endothelial Cells - Artery, donor2	11341-117F9	835.00	217.87	872.41	35.06	3.29	12.47
Endothelial Cells - Artery, donor3	11413-118E9	880.05	201.43	1011.18	36.46	2.45	5.61
Endothelial Cells - Lymphatic, donor1	11236-116D3	330.04	71.59	282.39	15.29	1.99	3.55
Endothelial Cells - Lymphatic, donor2	11317-117D3	291.49	99.50	220.90	12.78	3.04	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	150.25	99.23	62.86	6.20	1.97	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	286.44	182.44	146.49	18.13	5.05	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	299.38	134.85	449.33	24.47	2.60	1.56
Endothelial Cells - Microvascular, donor3	11414-118F1	249.12	164.90	30.63	4.25	1.84	1.28
Endothelial Cells - Thoracic, donor1	11266-116G6	462.94	194.06	455.74	30.41	4.00	2.40
Endothelial Cells - Thoracic, donor2	11343-117G2	238.48	158.81	221.18	16.77	2.62	5.24
Endothelial Cells - Umbilical vein, donor1	11243-116E1	1208.92	243.65	831.08	27.33	4.10	5.96
Endothelial Cells - Umbilical vein, donor2	11324-117E1	1030.91	188.58	809.74	21.94	3.91	6.08
Endothelial Cells - Umbilical vein, donor3	11400-118D5	1216.88	220.68	639.46	23.57	2.93	3.66
Endothelial Cells - Vein, donor1	11267-116G7	536.90	104.65	1440.08	45.50	7.96	2.28
Endothelial Cells - Vein, donor2	11344-117G3	657.99	172.53	2138.81	78.93	2.79	2.79
Endothelial Cells - Vein, donor3	11416-118F3	715.48	140.36	1064.98	37.37	5.97	4.08
Eosinophils, donor1	12244-129H3	0.00	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	77.56	315.20	9.90	26.40	0.00	0.00
Eosinophils, donor3	12246-129H5	32.10	196.18	10.70	7.13	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	270.71	218.43	28.83	17.59	7.09	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	58.24	297.46	8.32	4.16	6.24	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	146.42	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	37.77	51.72	19.29	6.57	1.23	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	71.82	56.06	31.20	8.32	6.13	1.53
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	141.06	113.00	134.99	18.42	4.44	2.38
Fibroblast - Aortic Adventitial, donor1	11245-116E3	143.11	97.02	104.06	19.04	4.00	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	67.42	28.39	34.53	5.19	2.87	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	87.64	125.19	20.99	7.59	8.44	0.74
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	40.31	44.27	54.54	8.17	6.06	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	325.56	130.55	453.45	36.87	6.98	1.33
Fibroblast - Cardiac, donor1	11268-116G8	88.91	78.02	67.14	9.07	3.18	0.91
Fibroblast - Cardiac, donor2	11345-117G4	144.77	194.79	69.73	10.61	3.79	0.76
Fibroblast - Cardiac, donor3	11417-118F4	64.35	73.97	30.91	11.20	5.05	0.32
Fibroblast - Cardiac, donor4	11452-119A3	233.70	143.07	45.47	6.67	5.46	0.30
Fibroblast - Cardiac, donor5	11456-119A7	167.39	122.34	71.07	9.77	3.93	2.16
Fibroblast - Cardiac, donor6	11460-119B2	212.23	108.39	96.72	10.76	3.79	1.67
Fibroblast - Choroid Plexus, donor1	11492-119E7	50.51	144.44	17.02	7.10	2.01	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	61.26	97.50	5.61	0.86	0.86	1.29
Fibroblast - Choroid Plexus, donor3	11653-122E6	380.85	246.09	95.21	20.51	1.46	8.79
Fibroblast - Conjunctival, donor1	11531-120A1	786.48	315.98	1739.48	75.19	10.38	2.77
Fibroblast - Conjunctival, donor3	11692-122I9	224.22	183.51	15.94	4.58	4.92	0.51
Fibroblast - Dermal, donor1	11269-116G9	477.78	96.26	1409.16	64.80	20.66	4.70
Fibroblast - Dermal, donor2	11346-117G5	623.56	246.69	1779.17	98.58	15.57	1.89
Fibroblast - Dermal, donor3	11418-118F5	637.31	155.94	1853.91	78.09	17.29	5.92
Fibroblast - Dermal, donor4	11450-119A1	731.40	247.80	539.68	28.49	8.25	10.63
Fibroblast - Dermal, donor5	11454-119A5	581.63	222.95	905.76	50.59	5.41	8.90
Fibroblast - Dermal, donor6	11458-119A9	651.80	242.17	1128.68	55.06	5.20	9.75
Fibroblast - Gingival, donor1	11237-116D4	573.26	135.14	1196.70	50.81	8.75	3.33
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	134.93	111.87	176.06	25.15	3.67	1.31
Fibroblast - Gingival, donor2	11318-117D4	769.35	146.28	3366.68	92.38	5.40	16.47
Fibroblast - Gingival, donor3	11394-118C8	500.26	190.67	638.71	25.62	9.48	5.61
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	74.80	56.10	47.79	15.58	5.19	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	48.98	72.95	52.51	6.34	5.99	1.23
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	200.02	115.83	220.44	41.00	4.83	1.71
Fibroblast - Gingival, donor6 (control)	11922-125H5	333.88	187.56	417.04	50.98	7.98	1.76
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	531.79	246.66	544.49	76.93	11.65	1.41
Fibroblast - Gingival, donor7 (control)	11924-125H7	156.77	127.53	145.66	23.40	4.39	1.17
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	91.22	95.31	80.58	20.73	6.95	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	212.70	142.27	211.38	33.13	8.12	1.43
Fibroblast - Gingival, donor9 (control)	11927-125I1	23.77	74.84	14.38	1.61	4.26	0.15
Fibroblast - Lung, donor1	11270-116H1	1370.22	265.07	1787.54	89.72	32.62	6.80
Fibroblast - Lung, donor2	11347-117G6	484.95	105.94	2841.06	104.45	19.40	7.46
Fibroblast - Lung, donor3	11419-118F6	974.99	158.07	4535.58	111.00	14.35	15.62
Fibroblast - Lymphatic, donor1	11506-119G3	1605.23	924.65	650.59	68.31	14.99	4.17
Fibroblast - Lymphatic, donor2	11586-120G2	370.64	337.07	90.91	13.99	5.59	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	359.36	321.86	83.12	13.71	10.64	1.96
Fibroblast - Mammary, donor1	11540-120B1	1639.30	809.50	418.15	56.43	19.49	2.44
Fibroblast - Mammary, donor2	11620-122A9	794.85	595.14	387.44	35.95	3.99	7.99
Fibroblast - Mammary, donor3	11701-123A9	482.46	351.42	83.39	11.91	5.96	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	574.36	151.30	1954.28	75.26	7.56	3.30
Fibroblast - Periodontal Ligament, donor2	11319-117D5	879.45	215.54	3624.13	99.65	8.80	25.79
Fibroblast - Periodontal Ligament, donor3	11395-118C9	734.68	197.97	1242.92	76.19	10.10	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	116.01	90.83	117.92	20.23	9.16	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	74.25	70.20	94.23	11.34	2.70	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	83.39	82.57	99.74	13.45	10.44	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	248.04	99.81	105.34	9.84	2.10	0.99
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	1320.33	451.69	389.72	38.81	15.85	2.64
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	835.25	263.27	2311.98	92.21	26.73	6.68
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	503.69	171.59	380.34	28.47	12.65	1.58
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	47.83	49.81	57.55	9.92	3.37	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	44.40	56.66	17.41	4.09	3.37	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	107.41	121.01	36.85	10.05	4.53	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	56.26	51.45	52.95	18.05	4.21	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	160.09	182.98	101.58	18.78	4.21	0.97
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	21.51	25.56	17.46	4.56	0.76	0.00
Fibroblast - skin normal, donor1	11553-120C5	62.51	86.96	41.18	8.04	4.43	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	119.10	52.93	71.38	14.84	3.41	0.40
Fibroblast - skin normal, donor2	11561-120D4	60.88	99.16	35.16	12.36	2.61	1.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	47.45	43.82	36.87	6.35	2.12	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	106.37	143.99	29.91	6.38	2.82	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	69.58	147.19	58.64	8.21	6.67	1.03
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	26.60	42.04	24.96	10.51	0.99	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	105.35	105.24	77.87	21.41	7.67	1.17
Fibroblast - skin walker warburg, donor1	11554-120C6	147.26	98.34	187.07	36.27	7.08	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	48.14	77.00	24.15	8.47	2.04	2.98
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	199.44	44.32	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	15.69	89.77	0.87	4.36	1.74	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	286.73	113.90	47.33	15.78	2.25	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	148.34	96.29	20.30	8.85	2.08	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	332.93	116.77	64.90	17.37	4.60	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	1039.62	752.54	58.18	8.42	7.66	5.36
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	1168.31	852.46	61.89	10.85	5.74	7.66
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	1046.92	674.93	71.60	9.98	7.99	7.13
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	518.70	566.13	10.75	8.27	13.51	2.76
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	390.67	267.60	17.12	9.36	9.82	1.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	974.21	560.31	62.01	8.92	6.14	3.76
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	567.00	577.31	12.16	8.46	11.37	2.11
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	359.09	202.21	11.42	7.50	13.70	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	896.83	608.94	52.18	5.31	3.98	3.54
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	619.70	608.25	37.45	9.47	5.94	4.38
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	573.60	463.51	44.45	11.45	3.94	4.43
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	1233.80	716.15	63.13	11.55	7.52	5.91
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	922.02	465.22	172.09	13.88	3.47	7.43
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	1086.23	653.93	211.79	14.40	4.84	11.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	1545.91	777.84	171.79	11.79	4.88	8.95
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	873.92	460.24	74.39	14.60	2.97	2.97
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	848.04	434.11	102.89	9.84	5.85	7.72
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	1433.42	647.86	128.30	10.71	4.37	7.21
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	592.73	409.24	39.30	12.71	2.66	3.25
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	409.32	310.29	48.64	14.15	3.66	3.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	962.05	394.11	52.06	10.50	6.03	2.90
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	459.32	387.54	37.71	19.96	3.02	2.62
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	298.23	226.30	48.52	18.83	1.70	4.24
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	890.62	392.99	64.38	17.47	4.52	1.60
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	740.46	628.71	46.72	32.78	7.91	0.94
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	538.63	606.43	39.45	31.59	7.86	1.54
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	226.29	224.07	28.88	21.25	2.55	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	503.50	291.69	35.52	16.64	4.08	0.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	419.39	307.90	30.63	19.81	4.49	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	306.57	337.31	26.82	18.77	2.68	1.44
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	183.32	226.55	23.17	20.87	2.88	1.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	305.18	245.31	28.35	23.51	2.00	1.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	234.32	328.88	23.81	18.08	3.53	1.76
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	140.33	248.81	22.75	16.36	4.55	1.97
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	275.72	240.38	31.61	19.78	3.24	1.46
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	217.77	363.69	15.39	14.11	5.13	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	120.91	170.18	30.98	22.84	2.56	1.04
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	213.85	254.19	31.32	22.30	3.16	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	215.29	293.75	40.14	25.85	1.52	2.43
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	153.25	151.37	54.36	26.34	2.51	1.05
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	144.25	222.19	21.96	15.15	4.39	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	181.51	204.80	33.39	20.76	1.96	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	101.57	104.90	63.24	34.35	3.33	1.11
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	146.00	176.49	39.04	27.28	5.08	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	288.57	151.78	152.09	49.57	2.30	1.22
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	111.14	101.17	79.79	32.13	2.46	1.42
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	111.95	149.63	17.62	23.58	4.07	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	87.01	120.75	35.58	20.83	3.32	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	78.29	135.54	26.76	16.45	1.97	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	129.92	302.48	10.91	26.78	6.94	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	114.63	114.76	76.77	19.13	2.11	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	139.62	122.87	152.12	24.41	4.44	1.21
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	104.21	329.39	8.39	26.18	7.62	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	962.46	1152.76	47.77	11.35	11.35	3.18
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	802.74	727.39	42.06	8.78	6.63	7.86
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	571.40	801.76	55.24	10.84	8.18	3.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	945.67	553.89	53.82	14.08	4.38	1.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	963.51	556.63	50.01	10.45	5.37	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	620.78	684.89	29.06	10.61	5.07	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	982.50	589.00	101.47	19.80	7.42	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	1137.99	598.01	71.95	20.89	4.64	5.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	620.93	662.65	83.43	17.65	4.81	6.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	801.60	412.10	36.52	10.43	6.96	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	924.69	420.84	38.73	14.00	1.63	3.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	812.90	517.63	30.47	12.35	4.12	2.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	513.17	376.55	10.00	16.66	0.00	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	701.92	364.10	27.69	12.02	3.64	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	776.58	449.41	29.74	13.40	5.56	3.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	567.89	410.19	16.78	12.58	0.84	5.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	692.44	472.02	16.54	10.81	5.41	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	762.54	490.81	27.85	13.59	4.76	3.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	384.22	327.84	20.88	10.44	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	746.80	694.68	13.74	13.17	7.45	2.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	636.07	550.53	11.54	7.40	1.18	2.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	374.41	250.73	16.94	10.16	5.08	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	662.73	403.02	25.27	14.50	4.14	6.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	828.46	449.67	21.17	15.42	4.83	3.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	295.04	189.67	10.54	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	439.77	346.74	11.15	8.46	4.23	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	442.67	293.37	8.15	7.50	4.24	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	248.81	194.63	8.03	4.01	4.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	477.35	547.85	13.87	9.25	5.39	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	500.50	413.89	13.01	11.64	5.82	1.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	270.84	407.51	2.48	2.48	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	495.91	554.90	6.13	6.13	5.66	2.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	427.27	482.19	6.03	9.66	6.03	3.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	308.26	371.33	9.66	5.09	3.56	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	518.09	483.39	10.77	11.17	7.18	1.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	304.40	373.47	4.44	8.88	4.93	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	233.73	459.19	3.54	4.72	5.90	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	307.48	491.85	6.42	9.34	7.00	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	246.21	461.27	5.71	4.83	4.83	2.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	245.83	401.81	3.39	7.63	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	219.07	225.63	5.37	7.76	2.39	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	227.58	219.82	7.76	3.40	4.37	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	109.57	90.16	49.08	18.26	4.57	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	101.46	92.31	29.52	11.64	3.33	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	946.79	265.37	1168.31	128.19	11.24	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	264.83	182.37	44.72	5.07	6.03	1.90
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	248.14	147.88	83.55	8.35	8.35	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	152.13	116.16	35.97	29.47	7.77	1.04
Hep-2 cells mock treated, biol_rep2	11899-125E9	131.16	129.64	36.12	29.71	10.63	1.18
Hep-2 cells mock treated, biol_rep3	11900-125F1	136.05	125.13	31.40	29.58	6.14	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	169.98	114.01	33.89	28.42	9.40	1.20
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	139.48	138.62	39.97	27.94	9.03	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	141.23	127.45	36.60	26.05	8.40	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	158.29	120.80	33.13	25.16	6.85	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	127.12	123.69	36.20	25.90	8.92	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	125.27	132.95	32.04	22.75	6.41	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	269.74	177.40	118.08	12.87	5.04	3.36
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	517.62	325.03	258.81	26.40	14.28	3.90
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	166.56	253.81	240.59	31.73	5.29	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	138.62	144.26	21.16	6.00	4.94	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	108.98	158.38	13.80	4.36	2.18	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	181.48	110.15	46.16	10.32	4.02	0.52
Hepatocyte, donor1	11523-119I2	0.00	7.26	0.00	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	4.31	21.55	1.08	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	1.84	6.14	0.00	1.23	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	129.88	183.40	14.36	5.22	21.54	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	126.89	122.00	5.42	5.77	5.94	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	428.63	129.93	146.26	23.60	8.10	0.69
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	719.56	843.73	92.33	25.47	31.84	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	507.32	794.36	53.40	20.03	13.35	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	406.25	1462.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	811.24	833.39	76.14	22.15	22.15	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	818.37	988.55	70.07	22.52	17.52	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	344.18	2065.08	47.47	35.60	0.00	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	761.18	912.40	94.83	10.25	12.81	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	676.47	955.29	63.99	36.57	13.71	13.71
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	503.54	1218.25	71.47	19.49	16.24	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	785.30	1018.72	86.70	20.01	11.67	10.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	501.02	1107.32	47.20	25.41	7.26	7.26
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	604.83	1085.25	79.41	11.91	17.21	7.94
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	833.70	889.13	87.58	15.52	24.39	4.43
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	576.21	1194.33	68.10	26.19	20.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	559.95	762.76	51.02	13.86	12.60	6.30
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	782.59	836.72	92.80	15.47	7.73	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	336.60	629.29	87.81	0.00	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	669.29	803.67	75.59	26.49	14.86	9.04
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	927.32	909.61	114.30	16.10	16.10	4.83
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	585.46	824.43	95.59	35.84	59.74	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	676.35	904.51	78.23	23.63	13.04	12.22
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	1093.61	1104.10	100.33	29.81	19.73	4.20
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	402.43	675.50	14.37	14.37	28.74	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	566.60	750.64	74.74	16.07	14.47	4.02
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	750.63	819.87	65.55	16.62	16.62	8.31
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	150.81	603.23	15.08	15.08	45.24	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	529.63	682.57	56.17	20.77	8.02	4.25
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	673.89	678.42	64.40	14.51	12.70	2.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	412.79	722.38	0.00	14.74	29.48	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	595.09	816.77	53.81	20.45	12.91	9.69
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	1012.56	1006.21	96.56	21.60	15.25	7.62
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	476.48	706.51	32.86	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	565.62	842.37	69.51	25.51	10.20	7.01
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	933.20	920.44	61.97	7.29	16.40	5.47
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	410.91	568.96	15.80	31.61	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	651.94	859.73	79.26	26.42	14.28	8.57
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	773.17	885.99	92.91	23.23	16.59	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	271.03	437.82	0.00	0.00	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	556.20	740.78	52.16	21.30	11.73	4.32
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	749.82	978.10	80.78	24.58	17.56	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	512.33	908.36	44.00	25.15	9.43	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	541.01	719.73	64.67	24.34	13.21	4.17
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	1223.84	1438.51	88.52	39.84	11.07	6.64
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	635.43	1196.30	45.39	25.94	19.45	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	705.39	1202.39	63.65	23.54	13.95	8.72
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	1138.39	1192.39	62.99	29.25	38.25	18.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	686.46	1000.07	62.72	20.91	13.94	10.45
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	746.74	1111.58	59.74	38.40	19.20	18.14
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	1037.70	1040.47	78.97	24.94	16.63	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	652.56	797.89	62.69	19.95	8.55	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	792.49	1002.34	69.03	27.61	19.33	11.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	883.39	1325.09	27.23	18.15	12.10	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	459.44	850.59	43.46	62.09	55.88	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	671.43	1220.21	37.01	30.66	25.38	13.75
Keratinocyte - epidermal, donor1	11272-116H3	141.57	205.06	13.30	10.04	3.10	0.24
Keratinocyte - epidermal, donor2	11349-117G8	414.63	356.07	51.54	14.06	4.10	0.00
Keratinocyte - epidermal, donor3	11421-118F8	493.35	278.86	68.44	15.24	4.54	1.99
Keratinocyte - oral, donor1	11251-116E9	747.17	458.72	55.17	21.80	9.31	2.61
Keratocytes, donor1	11527-119I6	536.72	354.49	779.47	67.73	5.85	1.38
Keratocytes, donor2	11607-120I5	495.67	206.24	1266.72	56.25	5.86	7.03
Keratocytes, donor3	11688-122I5	223.09	189.30	176.26	16.01	3.95	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	35.17	57.15	13.19	10.99	10.99	0.00
Lens Epithelial Cells, donor1	11529-119I8	536.14	220.06	299.89	22.65	5.39	2.16
Lens Epithelial Cells, donor2	11609-120I7	1117.45	292.94	79.35	16.26	11.07	1.04
Lens Epithelial Cells, donor3	11690-122I7	101.01	80.12	21.09	5.15	2.22	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	223.64	159.37	104.58	8.54	3.44	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	120.56	117.49	55.26	6.14	1.40	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	99.33	100.59	43.45	4.09	0.63	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	119.37	121.52	107.54	7.53	2.15	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	142.45	136.47	67.45	8.19	1.26	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	116.76	105.77	44.20	5.82	1.19	0.43
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	95.62	96.85	74.28	7.39	1.64	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	118.32	143.85	71.55	6.83	1.52	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	113.87	123.86	52.08	5.77	1.13	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	108.38	121.82	123.01	9.10	2.77	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	123.70	118.66	60.88	7.17	0.58	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	105.53	111.83	48.51	8.70	1.48	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	120.55	128.92	83.62	6.62	1.74	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	136.67	132.14	65.12	8.59	2.39	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	106.44	106.72	56.18	6.18	1.51	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	129.03	123.49	110.56	11.39	2.16	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	136.86	136.86	73.57	6.86	0.94	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	135.41	126.26	55.63	6.40	2.20	0.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	116.83	124.73	95.77	8.23	2.30	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	119.20	145.85	74.68	10.54	0.59	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	140.40	142.39	58.75	8.96	1.49	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	137.73	124.15	120.27	8.73	2.42	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	123.07	112.57	77.02	8.62	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	110.81	120.95	49.80	6.51	0.76	0.76
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	107.31	128.57	99.54	8.81	1.56	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	119.35	118.72	81.03	10.05	1.68	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	97.44	109.47	49.62	6.77	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	95.61	109.37	125.19	6.88	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	130.39	114.02	68.67	6.77	1.32	1.13
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	114.19	128.30	63.94	7.10	0.95	0.95
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	106.12	112.91	112.91	13.08	1.45	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	127.35	110.15	93.94	9.26	1.65	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	109.52	127.61	54.88	6.94	1.24	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	102.55	114.77	64.42	7.40	2.22	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	106.99	100.56	76.60	8.89	0.99	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	123.88	129.66	56.37	7.01	0.41	0.82
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	119.97	116.43	97.46	8.36	0.96	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	126.60	111.99	94.04	7.00	0.30	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	111.97	113.09	54.17	5.18	0.84	0.98
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	105.60	119.47	92.45	7.47	1.78	1.07
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	109.56	142.04	95.50	9.70	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	133.82	133.20	68.00	6.85	0.62	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	126.77	129.63	121.04	7.88	2.86	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	115.32	103.56	104.54	10.45	1.63	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	99.35	111.36	56.50	7.06	1.88	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	219.66	156.92	173.00	11.01	2.10	0.87
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	144.20	110.90	117.31	8.96	1.02	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	106.81	108.60	65.04	8.95	1.19	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	29.46	72.51	0.00	4.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	39.12	77.48	5.37	3.07	5.37	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	41.56	58.64	4.45	4.45	3.71	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	30.89	82.93	3.39	3.39	6.77	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	44.31	72.44	4.22	4.22	4.22	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	33.62	62.58	5.60	1.87	7.47	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	34.52	77.81	2.58	6.18	3.61	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	41.63	68.99	2.38	3.57	3.57	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	54.74	65.37	2.49	4.75	2.71	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	23.27	59.91	3.78	4.94	4.07	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	31.96	65.28	3.60	3.60	6.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	70.86	103.38	4.61	3.66	5.15	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	32.87	72.41	5.14	4.11	3.59	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	32.82	48.34	3.53	3.53	2.47	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	26.65	51.31	2.00	2.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	32.60	80.99	5.09	2.04	4.58	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	50.43	54.96	3.74	5.34	5.07	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	37.79	73.50	4.72	4.72	4.16	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	39.88	71.17	4.91	1.84	3.07	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	51.37	75.83	2.45	7.34	4.08	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	44.98	65.18	4.37	5.83	4.37	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	39.52	63.34	4.76	5.04	3.36	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	57.70	74.18	5.15	9.27	5.15	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	45.00	71.12	4.35	7.26	4.64	1.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	37.07	60.38	3.89	4.78	2.39	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	48.69	55.88	4.43	4.43	2.77	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	62.57	88.73	4.60	4.24	4.95	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	40.57	67.12	4.43	2.58	5.16	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	55.26	66.77	2.30	0.00	4.61	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	52.57	86.73	3.84	5.37	5.76	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	43.03	74.16	5.66	6.23	1.70	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	45.95	69.74	6.56	7.38	4.10	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	56.94	94.44	4.97	6.78	5.87	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	44.52	81.87	4.31	6.46	5.75	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	67.97	83.65	4.48	6.72	5.98	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	62.80	95.13	8.18	8.55	5.20	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	46.52	68.92	2.58	6.46	6.46	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	62.51	75.35	6.85	8.56	11.99	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	55.97	102.62	7.33	9.33	6.33	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	50.07	86.88	8.45	4.83	1.81	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	57.59	59.72	4.27	5.69	1.42	2.13
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	63.24	89.71	5.16	7.56	6.19	1.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	55.28	83.20	3.76	5.37	2.68	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	72.05	79.46	5.39	6.73	2.69	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	65.19	95.94	10.74	10.37	6.30	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	44.19	65.12	2.33	4.65	3.49	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	64.52	57.12	4.23	10.58	3.17	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	57.22	89.23	6.40	8.00	6.80	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	43.61	87.95	5.09	2.91	5.09	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	55.96	63.62	1.53	3.83	5.37	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	34.04	88.79	5.92	4.44	7.40	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	37.64	96.92	1.88	2.82	4.70	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	55.31	72.91	3.02	6.03	2.51	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	46.41	85.17	4.06	7.21	6.76	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	25.82	92.94	3.44	1.72	6.88	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	57.00	81.94	3.12	8.02	4.90	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	55.53	93.46	5.47	4.69	3.91	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	50.14	65.97	3.96	1.98	2.64	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	51.89	80.43	4.15	3.11	5.71	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	49.88	94.95	2.19	5.69	5.25	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	44.73	62.06	4.47	2.24	3.35	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	53.44	75.08	2.65	3.53	5.30	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	51.69	87.56	3.47	6.17	8.87	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	54.18	82.03	5.57	2.03	2.53	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	59.60	64.88	3.36	6.25	5.29	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	49.30	78.71	5.57	3.18	8.75	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	49.82	74.13	4.86	3.65	6.68	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	38.04	60.18	0.69	8.99	3.46	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	71.06	89.68	5.32	5.70	4.94	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	58.36	75.91	5.68	4.13	3.61	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	41.72	70.74	3.63	2.42	7.86	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	74.47	79.86	6.97	8.87	2.85	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	58.11	94.36	6.40	6.40	5.86	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	38.50	67.24	2.30	6.32	4.02	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	77.14	88.96	6.69	4.11	3.09	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	70.74	91.96	5.66	2.12	2.83	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	42.56	65.26	1.70	6.81	3.40	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	71.97	93.19	9.15	7.07	8.32	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	66.56	96.31	7.83	4.70	2.35	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	47.60	65.14	5.43	6.26	2.92	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	70.62	94.32	7.43	7.43	4.18	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	64.23	85.64	6.69	7.36	4.01	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	61.48	57.21	8.02	6.95	6.95	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	86.07	96.17	9.29	9.29	5.25	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	75.26	69.75	5.51	5.51	10.10	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	54.24	63.13	1.78	8.00	2.67	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	121.95	104.86	9.12	9.12	5.70	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	96.63	75.16	11.50	12.27	5.37	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	90.28	85.91	6.02	12.04	5.47	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	119.83	92.21	14.70	9.80	4.90	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	181.71	91.50	15.34	11.70	6.50	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	102.12	79.57	11.94	13.93	4.64	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	135.11	137.19	20.79	2.08	8.31	0.00
Macrophage - monocyte derived, donor1	11232-116C8	7.07	28.95	2.51	19.60	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	32.66	49.18	7.71	44.78	2.02	0.00
Macrophage - monocyte derived, donor3	11389-118C3	34.08	66.98	10.88	37.36	2.75	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	23.36	23.36	7.97	7.43	1.59	0.00
Mallassez-derived cells, donor2	11929-125I3	18.38	52.76	4.60	5.07	1.27	0.32
Mallassez-derived cells, donor3	11930-125I4	99.79	140.24	19.46	10.70	3.20	0.42
Mammary Epithelial Cell, donor1	11273-116H4	154.85	126.95	28.80	12.65	8.57	0.80
Mammary Epithelial Cell, donor2	11350-117G9	114.37	167.07	25.77	13.61	8.11	0.29
Mammary Epithelial Cell, donor3	11422-118F9	159.88	145.91	31.68	24.94	8.73	0.75
Mast cell - stimulated, donor1	11487-119E2	256.94	128.81	16.95	22.37	0.68	0.68
Mast cell, donor1	11563-120D6	19.57	49.53	0.65	1.62	0.97	0.00
Mast cell, donor2	11565-120D8	29.42	86.18	3.27	1.19	1.49	0.30
Mast cell, donor3	11566-120D9	11.93	76.54	2.03	0.90	0.45	0.00
Mast cell, donor4	11567-120E1	28.37	67.37	4.08	0.53	1.24	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	8.32	34.49	1.55	2.33	0.78	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	36.77	86.97	6.42	6.42	1.75	0.58
Mast cell, expanded, donor5	11939-126A4	5.16	33.96	0.57	1.49	1.15	0.23
Mast cell, expanded, donor8	11941-126A6	16.23	75.32	0.84	1.17	1.34	0.00
Melanocyte - dark, donor1	11502-119F8	160.99	131.83	45.27	4.68	1.09	0.20
Melanocyte - dark, donor2	11582-120F7	219.42	166.81	48.45	8.65	7.61	1.38
Melanocyte - dark, donor3	11663-122F7	113.08	115.76	77.00	50.93	6.30	0.43
Melanocyte - light, donor1	11274-116H5	98.50	133.99	79.69	69.35	10.11	0.71
Melanocyte - light, donor2	11351-117H1	39.58	165.16	21.84	45.73	10.92	0.00
Melanocyte - light, donor3	11423-118G1	83.25	98.86	67.64	49.43	2.60	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	138.28	123.08	79.45	31.34	4.17	2.29
Melanocyte, donor2 (MC+2)	12739-135I3	85.25	152.22	20.44	29.05	4.30	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	50.36	184.55	9.64	22.23	7.50	0.80
Meningeal Cells, donor1	11493-119E8	653.30	400.71	1500.38	174.80	10.42	1.36
Meningeal Cells, donor2	11573-120E7	130.28	161.53	75.27	21.13	6.60	1.32
Meningeal Cells, donor3	11654-122E7	670.11	240.35	1485.20	123.96	2.85	4.81
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	1102.13	160.83	1237.86	45.34	4.85	5.13
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	162.82	106.27	25.66	7.75	4.33	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	989.57	762.22	64.39	23.65	9.20	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	841.15	359.74	1102.78	64.10	3.92	3.92
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	342.30	209.54	298.52	22.25	3.59	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	81.32	70.31	21.18	6.56	3.81	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	117.12	76.90	42.72	13.57	7.04	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	1004.27	266.56	747.60	45.27	5.49	2.20
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	1068.85	265.20	1099.53	55.52	5.11	5.84
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	1128.79	234.88	1134.73	55.04	5.52	5.52
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	230.61	149.31	32.13	4.71	6.65	0.97
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	53.53	135.31	10.78	4.46	3.72	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	83.55	206.97	6.71	4.08	3.42	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	60.53	128.49	1.48	1.19	1.19	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	116.78	240.56	4.67	9.34	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	277.93	201.09	87.73	12.81	8.33	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	416.12	164.82	282.49	33.67	5.67	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	73.18	132.91	5.32	2.19	1.88	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	219.88	174.17	65.31	15.24	7.26	1.45
Mesothelial Cells, donor1	11247-116E5	297.00	86.71	53.04	7.69	7.69	0.27
Mesothelial Cells, donor2	12156-128G5	206.19	84.08	66.56	14.01	9.51	0.00
Mesothelial Cells, donor3	11402-118D7	318.98	110.56	54.63	9.03	5.49	1.73
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	21.61	39.16	6.75	40.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	38.91	56.15	8.87	41.87	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	31.80	57.42	6.77	26.80	0.59	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	3.46	3.46	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	24.49	33.16	5.89	24.49	1.86	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	26.76	45.64	4.77	24.06	1.24	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	9.26	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	30.28	61.56	8.01	33.28	1.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	34.91	65.63	6.05	27.93	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	38.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	28.25	49.38	5.89	30.48	0.61	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	21.38	51.87	5.54	27.72	1.19	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	8.55	0.00	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	20.35	46.02	3.54	37.17	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	26.98	50.53	7.60	30.02	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	10.53	1.32	17.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	28.65	46.69	6.15	28.23	0.85	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	13.81	26.70	4.60	16.57	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	24.44	38.15	5.96	21.76	1.79	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	11.74	21.80	3.35	21.80	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	33.95	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	26.09	44.16	7.03	22.58	0.50	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	24.48	44.21	5.23	24.00	0.48	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	3.32	8.29	0.55	8.29	1.11	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	16.35	30.16	5.07	25.33	1.38	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	25.24	38.49	3.79	19.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	17.33	27.11	5.50	13.25	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	18.88	34.76	6.22	24.67	0.21	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	25.12	36.90	5.11	19.34	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	20.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	17.30	29.13	5.91	21.03	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	24.84	32.95	5.58	22.31	1.52	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	11.60	4.97	13.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	19.57	30.17	7.34	23.10	0.54	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	22.06	29.70	7.06	19.41	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	5.45	14.17	1.09	4.36	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	20.18	29.31	7.21	21.62	0.96	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	22.81	32.42	4.40	23.61	0.80	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	8.23	10.97	4.11	16.45	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	22.53	32.54	9.01	19.52	1.50	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	53.89	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	10.19	6.12	12.23	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	10.07	19.27	2.63	19.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	11.04	14.35	3.31	13.24	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	8.97	10.89	2.56	11.53	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	18.10	31.73	6.20	25.04	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	20.88	23.66	7.65	29.23	2.09	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	8.84	2.21	13.26	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	15.04	37.26	6.15	24.62	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	21.44	20.13	3.94	18.82	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	8.17	12.78	8.17	9.59	0.71	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	23.29	24.69	10.10	25.81	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	28.68	19.95	8.73	24.11	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	12.82	15.73	8.16	15.15	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	20.21	25.94	10.26	26.55	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	30.89	29.22	10.43	30.47	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	14.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	11.08	28.63	11.08	18.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	40.98	31.30	12.52	29.03	1.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	10.64	19.48	8.15	19.35	0.41	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	20.73	27.99	13.22	28.51	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	36.03	38.18	8.58	24.88	0.86	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	11.43	15.24	4.45	12.07	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	17.08	24.29	11.21	28.02	1.07	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	39.81	39.51	8.68	27.24	1.80	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	7.20	15.96	5.37	17.37	0.42	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	19.11	28.35	10.83	20.07	0.96	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	54.84	36.04	8.85	26.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	10.62	15.55	7.20	12.51	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	15.91	25.00	6.82	23.30	0.28	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	54.57	41.05	8.85	25.81	0.49	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	5.87	18.25	1.96	5.21	1.96	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	19.70	30.28	7.94	24.99	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	50.46	47.86	6.34	24.22	1.44	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	18.13	41.21	2.06	22.67	2.06	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	18.16	42.29	6.85	35.14	2.08	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	48.97	0.00	22.60	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	12.48	28.52	1.78	12.48	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	9.86	55.86	6.57	27.27	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	9.47	75.74	11.57	30.51	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	5.34	33.21	2.17	21.35	0.40	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	11.18	43.77	5.59	36.32	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	5.26	37.18	4.51	27.79	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	12.25	41.55	2.40	37.29	0.80	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	4.64	39.25	1.70	20.81	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	5.89	53.78	2.95	24.31	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	6.96	48.00	2.56	32.61	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	12.44	63.78	7.78	37.33	1.56	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	12.83	66.27	10.15	26.19	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	46.37	0.00	23.18	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	14.14	60.60	2.02	26.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	23.19	84.33	10.12	49.75	1.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	24.51	38.13	6.81	25.88	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	16.53	38.15	5.72	24.80	1.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	7.29	20.25	4.05	17.82	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	21.15	74.01	6.04	39.27	4.53	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	45.68	45.68	45.68	28.55	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	48.94	81.56	48.94	45.67	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	42.77	33.27	57.03	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	100.39	62.75	0.00	37.65	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	86.61	76.91	65.49	17.23	1.72	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	18.29	61.67	9.41	4.70	2.09	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	296.36	155.52	292.36	44.05	30.70	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	274.63	106.85	288.82	42.15	11.27	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	195.66	127.78	160.67	27.57	6.08	2.85
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	547.38	405.35	464.39	110.11	33.51	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	152.31	122.39	152.31	21.08	6.12	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	213.17	134.15	387.74	90.04	11.03	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	156.95	112.59	98.36	14.23	17.16	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	216.63	105.76	247.31	28.13	8.60	0.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	177.27	166.46	83.77	18.11	5.67	2.43
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	126.35	164.83	44.99	14.30	7.15	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	211.56	267.23	144.75	77.94	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	145.43	114.66	67.50	18.37	9.93	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	55.76	83.91	11.37	4.87	5.41	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	149.61	103.59	64.15	13.37	9.07	1.59
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	92.59	106.80	28.90	4.90	6.04	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	48.66	112.82	7.65	4.92	2.37	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	68.43	101.31	10.61	3.18	8.49	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	63.63	80.44	10.21	4.20	2.40	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	28.55	86.64	7.55	4.27	3.94	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	68.46	87.00	13.34	4.07	4.23	1.30
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	31.40	116.41	6.70	5.82	3.00	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	17.58	59.77	4.22	3.52	4.22	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	25.28	78.15	5.98	1.38	2.76	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	30.53	69.09	7.71	2.25	5.78	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	27.94	79.32	7.93	2.07	2.76	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	131.48	270.54	35.40	22.76	2.53	7.59
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	13.81	67.50	3.34	3.79	2.01	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	24.56	59.27	5.50	1.69	2.54	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	19.46	62.42	4.51	3.32	2.85	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	24.47	48.93	4.29	3.43	3.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	63.19	207.64	45.14	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	44.98	90.97	13.33	3.00	1.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	9.47	60.87	3.16	2.71	2.25	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	9.13	36.11	1.98	1.59	1.19	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	44.57	70.58	13.93	4.64	1.86	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	14.38	35.95	3.41	1.14	2.27	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	28.03	44.32	14.34	3.26	2.61	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	47.50	99.79	7.84	2.18	3.92	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	8.14	45.23	2.71	1.81	1.36	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	5.29	44.10	2.65	3.53	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	23.27	54.52	4.65	2.66	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	12.90	39.19	2.48	1.49	1.98	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	18.38	36.37	8.04	1.91	1.15	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	22.08	52.32	3.33	3.02	2.42	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	15.69	55.03	2.21	3.09	1.77	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	6.78	39.98	0.68	1.36	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	35.77	61.31	10.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	8.54	31.70	3.05	1.22	2.44	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	13.85	21.40	5.04	0.63	1.57	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	33.29	98.36	4.24	1.51	2.42	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	6.33	39.56	1.58	0.00	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	5.67	38.54	4.53	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	65.75	5.06	15.17	5.06	0.00
Myoblast, donor1	11241-116D8	104.97	55.90	50.06	12.55	4.35	0.25
Myoblast, donor2	11322-117D8	410.24	155.92	299.57	28.00	13.62	3.07
Myoblast, donor3	11398-118D3	61.38	55.33	24.22	9.75	5.21	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	118.35	172.20	12.40	10.94	5.25	0.15
Natural Killer Cells, donor1	11230-116C6	16.91	95.64	5.84	5.23	1.54	0.00
Natural Killer Cells, donor2	11311-117C6	19.30	123.94	6.94	6.33	3.92	0.00
Natural Killer Cells, donor3	11387-118C1	15.46	93.32	4.79	4.60	2.21	0.37
Neural stem cells, donor1	11275-116H6	305.96	274.38	95.45	37.38	6.17	1.09
Neural stem cells, donor2	11352-117H2	310.03	383.20	146.35	32.74	13.48	0.00
Neurons, donor1	11494-119E9	113.79	223.03	54.62	22.76	5.69	1.14
Neurons, donor2	11574-120E8	147.51	149.93	79.92	16.07	0.88	1.10
Neurons, donor3	11655-122E8	126.61	180.05	46.86	13.98	3.29	2.47
Neutrophils, donor1	11233-116C9	5.57	54.75	1.86	2.78	0.00	0.00
Neutrophils, donor2	11314-117C9	5.80	55.08	0.00	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	9.77	57.42	0.61	2.44	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	396.58	195.56	23.39	4.04	3.68	1.54
Nucleus Pulposus Cell, donor2	11409-118E5	480.92	203.50	79.12	7.49	5.86	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	475.91	195.74	154.83	9.23	8.62	2.81
Olfactory epithelial cells, donor1	11933-125I7	16.66	43.22	9.77	4.27	1.24	0.00
Olfactory epithelial cells, donor2	11934-125I8	36.62	61.37	26.92	9.70	1.88	1.01
Olfactory epithelial cells, donor3	11935-125I9	20.88	40.29	9.87	1.82	0.45	0.00
Olfactory epithelial cells, donor4	11936-126A1	45.58	74.51	21.04	3.31	1.36	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	808.24	232.90	119.16	7.82	7.22	0.60
Osteoblast - differentiated, donor1	11276-116H7	172.28	159.31	59.98	8.72	7.87	0.00
Osteoblast - differentiated, donor2	11353-117H3	51.44	56.01	20.58	3.43	5.72	2.29
Osteoblast - differentiated, donor3	11425-118G3	199.25	171.32	135.94	11.79	6.21	0.62
Osteoblast, donor1	11277-116H8	653.15	282.99	342.80	45.34	19.35	1.56
Osteoblast, donor2	11354-117H4	342.73	191.73	261.26	33.71	14.05	0.70
Osteoblast, donor3	11426-118G4	584.38	190.70	342.31	42.30	11.73	1.78
Pancreatic stromal cells, donor1	11249-116E7	439.46	171.76	268.12	27.12	11.71	1.60
Pericytes, donor1	11491-119E6	157.00	270.82	64.42	12.57	6.01	0.78
Pericytes, donor2	11571-120E5	72.21	162.53	21.28	8.15	2.04	0.68
Pericytes, donor3	11652-122E5	268.96	197.75	101.32	14.24	3.26	1.22
Perineurial Cells, donor1	11499-119F5	620.71	199.26	342.57	35.71	5.88	1.58
Perineurial Cells, donor2	11579-120F4	429.97	185.31	62.11	10.31	9.20	0.92
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	20.40	108.69	2.87	12.43	1.59	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	14.69	118.76	3.18	12.00	1.22	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	15.40	109.36	5.56	12.68	1.29	0.00
Placental Epithelial Cells, donor1	11278-116H9	303.98	126.76	45.44	10.04	0.96	0.00
Placental Epithelial Cells, donor2	11355-117H5	167.44	178.53	83.17	7.76	5.54	0.00
Placental Epithelial Cells, donor3	11427-118G5	186.12	170.02	56.15	8.25	6.28	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	2.53	19.30	2.85	1.90	0.63	0.63
Preadipocyte - breast, donor1	11467-119B9	12.01	34.14	3.75	2.06	0.75	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	5.61	6.40	3.26	1.70	0.13	0.00
Preadipocyte - breast, donor2	11328-117E5	10.36	37.82	4.50	1.35	0.68	0.23
Preadipocyte - omental, donor1	11468-119C1	11.30	35.80	2.24	1.49	0.64	0.00
Preadipocyte - omental, donor2	11329-117E6	6.55	27.93	4.80	1.31	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	30.66	27.22	12.46	4.73	1.58	0.14
Preadipocyte - perirenal, donor1	11469-119C2	0.98	33.47	4.92	1.97	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	436.41	234.94	223.27	39.62	13.21	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	652.35	297.49	437.91	44.09	9.74	6.20
Preadipocyte - subcutaneous, donor3	11428-118G6	226.82	185.44	130.95	24.86	10.73	1.36
Preadipocyte - visceral, donor1	11280-116I2	469.46	191.60	461.64	51.70	12.85	1.21
Preadipocyte - visceral, donor2	11357-117H7	450.52	366.30	315.22	34.51	12.42	5.06
Preadipocyte - visceral, donor3	11429-118G7	265.30	137.82	389.02	38.35	10.24	5.33
Prostate Epithelial Cells (polarized), donor1	11253-116F2	185.25	161.11	7.84	6.49	7.39	0.45
Prostate Epithelial Cells, donor2	11331-117E8	58.77	54.03	14.35	5.55	1.35	0.27
Prostate Epithelial Cells, donor3	11404-118D9	222.17	185.55	19.11	6.86	3.43	1.96
Prostate Stromal Cells, donor1	11254-116F3	235.32	99.55	129.62	13.10	4.33	0.57
Prostate Stromal Cells, donor2	11332-117E9	590.43	185.39	377.96	27.61	6.81	2.87
Prostate Stromal Cells, donor3	11405-118E1	144.63	99.27	76.43	7.82	4.90	1.15
Renal Cortical Epithelial Cells, donor1	11516-119H4	1366.49	416.08	552.95	29.56	7.66	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	871.87	308.99	286.26	13.45	3.40	2.29
Renal Epithelial Cells, donor1	11517-119H5	1574.95	641.65	655.85	54.78	9.64	5.58
Renal Epithelial Cells, donor2	11597-120H4	897.69	389.80	576.88	37.70	17.07	5.69
Renal Epithelial Cells, donor3	11678-122H4	906.31	416.58	266.99	14.93	7.52	2.12
Renal Glomerular Endothelial Cells, donor1	11514-119H2	300.94	189.28	270.30	19.06	0.68	2.04
Renal Glomerular Endothelial Cells, donor2	11594-120H1	621.26	195.68	510.22	21.43	4.31	7.14
Renal Glomerular Endothelial Cells, donor3	11675-122H1	407.17	166.95	236.00	24.87	2.66	2.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	217.60	224.25	139.74	9.32	4.66	0.67
Renal Mesangial Cells, donor1	11518-119H6	732.89	270.05	402.98	35.65	9.68	2.20
Renal Mesangial Cells, donor2	11598-120H5	425.10	370.55	117.25	20.69	9.40	1.25
Renal Mesangial Cells, donor3	11679-122H5	518.76	287.68	120.95	15.54	7.77	1.66
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	1361.17	344.92	748.90	40.53	14.76	2.68
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	923.51	293.08	387.11	18.98	5.06	2.95
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	1438.83	359.27	700.42	46.09	16.97	4.44
Retinal Pigment Epithelial Cells, donor0	11215-116A9	1586.80	162.05	404.74	16.59	7.52	4.67
Retinal Pigment Epithelial Cells, donor1	11528-119I7	713.17	266.62	94.08	20.18	11.09	1.42
Retinal Pigment Epithelial Cells, donor2	11608-120I6	813.01	279.92	225.38	32.93	5.15	4.12
Retinal Pigment Epithelial Cells, donor3	11689-122I6	472.21	275.75	290.80	18.82	4.77	2.01
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	45.17	50.65	4.81	3.47	1.87	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	9.83	85.77	0.89	0.89	2.68	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	14.86	124.93	1.65	3.85	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	5.22	122.39	1.74	3.48	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	12.48	72.03	4.42	7.28	2.08	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	21.75	71.80	6.75	6.65	1.09	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	17.96	64.47	6.92	5.13	1.67	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	19.60	72.44	7.57	6.57	1.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	21.44	78.78	7.93	8.27	1.17	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	27.27	103.32	6.01	6.70	1.85	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	7.94	62.16	3.29	6.43	1.78	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	19.51	68.38	6.96	6.96	0.76	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	16.84	50.17	5.73	4.48	1.43	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	10.62	66.13	4.02	5.45	0.86	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	20.60	69.54	6.33	7.30	1.07	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	17.26	65.05	6.64	5.97	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	7.26	67.10	2.68	7.07	1.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	17.05	60.28	6.61	6.71	1.21	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	24.05	91.89	6.58	6.39	1.50	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	11.94	54.41	5.31	6.24	1.06	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	19.76	70.57	6.62	7.50	1.65	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	21.96	65.31	5.73	8.40	1.34	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	10.04	55.85	4.16	6.62	1.28	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	17.10	68.67	5.05	7.29	0.56	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	15.72	68.19	5.64	8.03	1.71	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	9.12	53.61	3.10	4.74	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	18.52	69.53	6.50	6.38	1.47	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	16.66	72.13	4.43	7.92	1.75	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	6.60	61.56	4.01	8.26	0.94	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	21.43	77.98	4.76	6.94	1.19	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	15.20	63.61	5.14	6.31	2.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	8.50	59.10	2.70	8.50	0.62	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	16.81	79.64	5.97	6.86	1.33	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	16.71	64.13	4.39	6.06	1.25	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	10.50	51.01	2.69	7.00	1.35	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	13.62	48.87	5.62	7.66	0.85	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	14.85	59.19	5.21	8.10	1.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	6.71	48.66	4.47	7.22	0.86	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	13.58	41.15	5.49	5.21	1.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	12.64	41.53	5.75	4.60	1.48	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	7.67	58.97	4.77	5.79	1.19	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	15.83	55.93	5.33	8.29	1.18	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	14.39	52.51	6.13	6.13	2.93	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	16.59	111.44	6.22	7.33	3.32	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	21.67	95.72	7.14	9.05	3.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	32.25	125.36	5.84	10.28	2.42	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	15.54	102.65	3.48	6.12	2.73	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	22.36	137.30	8.38	6.29	2.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	17.83	90.36	5.14	3.32	1.81	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	15.30	88.73	4.04	4.65	1.96	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	14.41	81.80	4.95	4.37	4.66	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	17.64	86.40	4.87	6.08	3.65	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	9.95	79.87	3.01	2.71	0.90	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	21.94	100.88	5.43	7.69	3.17	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	21.87	129.70	5.39	5.09	3.89	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	14.52	92.10	3.19	4.72	3.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	24.33	108.00	4.06	5.98	4.06	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	19.83	133.42	4.81	4.21	3.00	0.00
Schwann Cells, donor1	11498-119F4	585.47	281.92	905.56	70.15	9.59	6.39
Schwann Cells, donor2	11578-120F3	357.25	163.32	1942.78	125.89	0.00	6.80
Schwann Cells, donor3	11659-122F3	248.88	152.04	262.24	40.53	12.49	2.85
Sebocyte, donor1	11220-116B5	269.50	282.10	79.97	24.65	7.67	0.55
Sebocyte, donor2	11301-117B5	199.45	233.91	37.68	12.41	5.97	0.46
Sebocyte, donor3	11378-118B1	366.26	426.86	60.60	10.10	7.01	2.89
Sertoli Cells, donor1	11255-116F4	67.92	59.64	18.22	13.25	1.66	0.00
Sertoli Cells, donor2	11333-117F1	39.54	124.27	5.65	2.82	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	986.85	453.35	255.66	32.82	10.29	1.41
Skeletal Muscle Cells, donor2	11358-117H8	173.48	236.37	13.01	11.57	6.51	1.45
Skeletal Muscle Cells, donor3	11430-118G8	1281.65	500.79	1242.35	105.34	18.39	8.36
Skeletal Muscle Cells, donor4	11451-119A2	481.49	170.60	309.16	22.94	6.28	3.14
Skeletal Muscle Cells, donor5	11455-119A6	371.91	179.86	199.18	15.31	6.84	2.97
Skeletal Muscle Cells, donor6	11459-119B1	624.07	210.85	582.98	28.93	4.16	5.39
Skeletal Muscle Satellite Cells, donor1	11240-116D7	674.01	246.72	107.74	11.97	3.91	2.65
Skeletal Muscle Satellite Cells, donor2	11321-117D7	551.35	194.48	139.26	11.42	3.14	2.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	888.52	233.64	592.38	29.27	8.53	5.36
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	48.28	75.41	5.64	5.64	2.19	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	1218.82	322.80	1808.68	102.05	13.03	6.51
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	299.69	177.92	477.33	46.78	8.39	3.16
Skin - palm, donor1	10286-104F7	2.69	32.23	2.69	0.00	5.37	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	60.26	75.97	17.88	4.61	1.73	0.86
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	7.36	27.81	6.54	0.00	3.27	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	79.32	88.15	23.89	6.62	2.60	1.04
Small Airway Epithelial Cells, donor1	11256-116F5	118.30	115.93	16.26	6.67	2.50	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	133.20	96.77	23.35	10.69	1.41	1.27
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	72.53	46.52	15.44	4.65	6.13	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	145.93	137.16	15.29	8.99	2.25	0.52
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	104.61	243.47	74.06	23.76	8.33	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	43.58	52.69	36.24	6.45	2.22	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	672.47	279.22	442.63	54.08	10.58	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	380.77	202.87	197.12	26.52	8.18	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	373.30	183.11	354.01	46.47	16.14	1.58
Smooth Muscle Cells - Aortic, donor3	11432-118H1	638.91	324.48	472.04	43.26	10.04	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	85.06	155.12	3.00	2.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	452.20	208.53	450.73	57.09	11.44	0.80
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	197.72	138.09	138.31	17.29	15.07	2.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	77.07	57.10	48.01	9.35	2.43	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	120.47	78.79	65.77	15.30	3.58	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	103.36	92.44	36.03	10.04	5.32	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	30.61	57.37	6.98	3.27	2.28	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	736.27	225.14	462.16	34.65	26.84	2.11
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	158.31	92.55	43.23	3.35	7.00	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	916.05	317.98	584.68	61.12	18.69	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	257.07	306.04	201.98	55.09	12.24	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	279.43	203.13	227.45	34.81	10.49	2.86
Smooth Muscle Cells - Colonic, donor1	11239-116D6	126.68	84.65	23.45	3.83	3.83	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	164.01	125.70	27.34	6.67	3.66	1.94
Smooth Muscle Cells - Colonic, donor3	11396-118D1	299.97	138.12	81.97	10.92	5.77	1.89
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	495.90	211.60	409.90	59.71	15.62	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	272.70	164.92	311.51	49.58	18.32	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	213.08	147.34	116.85	23.91	5.68	1.20
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	393.29	257.07	87.74	19.46	12.97	1.37
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	296.05	200.25	6.99	3.14	5.03	1.02
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	698.35	167.27	662.32	45.19	19.63	2.42
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	389.34	151.32	242.34	20.93	12.74	2.28
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	164.84	281.98	209.52	39.85	15.70	2.42
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	1096.53	276.05	497.80	25.17	9.27	1.32
Smooth Muscle Cells - Prostate, donor1	11257-116F6	175.37	92.55	191.35	22.10	5.86	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	150.64	96.04	31.56	7.39	4.88	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	87.26	97.41	9.13	3.55	3.80	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	341.80	175.65	365.62	46.59	9.35	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	665.40	309.82	519.12	46.51	14.25	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	266.20	245.52	432.89	33.60	3.88	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	546.46	339.50	326.48	50.69	9.77	1.86
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	359.98	160.05	330.19	34.33	10.60	3.03
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	180.83	104.99	231.91	34.47	9.40	3.45
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	406.21	118.29	273.17	28.02	25.66	0.88
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	1021.84	189.77	1056.58	58.06	13.66	1.92
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	350.37	148.09	71.01	8.88	7.47	1.87
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	323.67	176.59	240.49	37.99	7.77	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	506.09	215.18	357.45	42.07	7.14	2.04
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	382.27	205.14	279.61	37.42	5.83	1.13
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	839.58	259.78	224.01	24.46	17.05	1.96
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	138.75	129.79	18.68	3.77	4.78	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	764.27	477.61	157.14	9.05	11.90	2.38
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	323.44	156.58	242.70	40.37	6.61	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	193.55	119.53	96.33	14.36	6.63	1.55
Smooth Muscle Cells - Uterine, donor3	11466-119B8	664.15	232.60	644.26	51.79	7.31	2.93
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	11.27	39.26	1.94	1.75	1.36	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	54.21	70.61	24.33	9.78	2.38	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	45.75	92.99	18.23	2.23	1.86	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	110.68	100.97	59.65	14.73	7.19	1.80
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	101.64	43.72	164.09	20.16	9.37	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	96.50	102.41	90.59	27.18	3.15	4.73
Smooth muscle cells - airway, control, donor1	11966-126D4	76.95	95.74	60.69	9.65	4.83	1.52
Smooth muscle cells - airway, control, donor2	11967-126D5	66.29	92.24	35.94	5.99	5.99	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	27.17	57.68	11.70	2.51	2.51	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	27.96	55.46	21.08	0.92	1.38	0.00
Synoviocyte, donor1	11291-117A4	93.92	72.38	49.82	8.75	2.19	0.17
Synoviocyte, donor2	11368-117I9	34.87	66.38	8.21	2.85	2.35	0.50
Synoviocyte, donor3	11440-118H9	21.00	43.79	7.82	2.68	1.12	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	601.75	303.02	1725.19	91.83	16.44	2.86
Trabecular Meshwork Cells, donor2	11612-122A1	394.43	267.58	434.07	21.80	13.87	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	403.12	264.66	696.49	50.94	8.10	2.08
Tracheal Epithelial Cells, donor1	11292-117A5	520.79	308.96	56.27	18.28	2.44	0.72
Tracheal Epithelial Cells, donor2	11369-118A1	664.11	298.43	89.30	18.56	2.71	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	235.36	284.61	50.97	25.77	1.15	1.72
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	49.09	47.61	5.66	4.18	1.85	0.00
Urethra, donor2	10319-105A4	5.40	28.77	5.40	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	123.00	144.25	22.58	9.03	1.86	0.00
Urothelial Cells, donor2	11600-120H7	70.10	138.19	14.02	4.41	1.60	2.00
Urothelial Cells, donor3	11681-122H7	119.19	168.01	14.90	4.81	0.92	0.46
Urothelial cells, donor0	11216-116B1	257.67	235.38	33.21	8.69	1.56	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	12.46	87.20	1.78	1.78	1.78	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	8.58	81.49	0.00	5.72	2.86	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	9.58	84.88	2.74	4.79	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	13.08	78.85	1.38	6.89	1.72	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	16.27	92.38	2.32	4.07	1.74	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	8.33	52.06	2.08	4.16	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	11.93	81.68	1.84	1.84	3.67	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	10.04	85.81	2.74	5.48	2.74	0.00
Wilms' tumor cell line:G-401	10809-111A8	513.55	214.90	232.54	33.80	4.44	1.73
Wilms' tumor cell line:HFWT	10597-108E3	43.12	146.97	11.44	7.92	7.04	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	550.54	560.31	44.41	33.52	1.96	3.35
achilles tendon, donor2	10292-104G4	45.46	68.20	14.47	10.33	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	406.91	284.53	190.45	207.28	13.51	1.27
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	127.00	104.01	250.28	143.72	5.57	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	527.18	361.23	31.46	15.19	21.72	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	347.76	294.16	48.44	8.44	9.25	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	425.56	609.95	49.19	48.91	6.46	2.81
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	71.06	208.52	5.08	16.28	2.54	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	203.89	439.62	19.87	43.55	1.91	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	274.08	533.17	38.78	5.73	1.76	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	73.50	376.10	4.08	11.43	4.49	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	275.69	222.49	46.21	98.24	11.26	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	318.69	782.55	28.70	27.60	4.97	2.02
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	85.81	401.75	7.80	11.70	42.91	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	451.29	455.24	40.67	13.01	5.34	3.02
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	294.11	742.01	48.41	239.48	4.92	4.66
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	247.53	498.28	53.19	206.03	2.92	2.63
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	73.90	186.83	11.62	112.47	4.18	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	44.00	138.59	4.94	41.54	7.40	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	162.07	321.07	137.82	151.33	5.22	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	217.19	235.54	115.21	340.51	7.25	2.56
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	191.38	199.26	101.30	299.35	9.71	2.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	267.18	262.61	137.44	357.93	8.91	1.20
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	306.71	576.89	28.96	68.83	18.49	1.56
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	326.88	413.26	52.37	17.68	7.34	1.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	172.81	367.92	24.16	31.59	14.87	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	126.93	340.12	14.31	8.29	1.51	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	86.79	358.50	6.11	17.01	7.85	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	48.74	99.35	3.75	20.62	5.62	0.00
adenocarcinoma cell line:IM95m	10796-110I4	243.04	292.49	14.13	6.59	11.54	1.41
adipose tissue, adult, pool1	10010-101C1	20.32	50.57	4.65	6.98	0.62	0.16
adipose, donor1	10184-103D4	481.44	495.52	16.42	10.56	8.21	2.93
adipose, donor2	10185-103D5	183.70	171.94	8.92	5.68	4.06	1.22
adipose, donor3	10186-103D6	280.73	203.94	14.43	11.71	6.53	0.27
adipose, donor4	10187-103D7	517.45	451.58	41.60	18.20	1.73	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	205.96	265.93	29.67	9.47	3.16	1.26
adrenal gland, adult, pool1	10081-102A9	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	80.58	312.44	4.40	28.95	4.54	0.80
alveolar cell carcinoma cell line:SW 1573	10708-109H6	657.43	343.72	251.90	45.02	18.94	2.86
amniotic membrane cells, donor1	12235-129G3	60.98	86.94	3.48	1.62	0.93	0.23
amniotic membrane cells, donor2	12236-129G4	52.07	77.43	3.72	1.69	3.04	0.00
amniotic membrane cells, donor3	12237-129G5	40.65	118.72	1.18	0.88	0.29	0.00
amygdala - adult, donor10196	10167-103B5	4.74	73.52	3.56	2.37	2.37	1.19
amygdala, adult, donor10252	10151-102I7	11.35	56.17	2.43	5.47	2.84	0.20
amygdala, newborn, donor10223	10360-105E9	19.04	34.54	7.42	3.55	6.13	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	1695.65	245.87	382.88	24.70	7.77	1.78
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	674.00	496.18	68.61	21.62	3.09	1.99
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	19.04	107.89	1.67	9.02	11.02	0.33
aorta, adult, pool1	10052-101G7	8.83	24.32	3.14	2.16	0.59	0.20
appendix, adult	10189-103D9	77.62	142.44	25.23	15.14	5.43	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	339.12	635.59	25.80	10.66	21.67	0.69
artery, adult	10190-103E1	23.10	16.30	2.72	6.79	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	316.10	232.95	55.92	24.77	16.66	0.43
b cell line:RPMI1788	10427-106D4	296.66	386.33	92.34	142.90	5.20	0.89
basal cell carcinoma cell line:TE 354.T	10702-109G9	120.41	93.22	87.67	14.43	3.33	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	783.04	131.38	621.89	31.36	6.55	1.49
bile duct carcinoma cell line:TFK-1	10496-107C1	165.70	66.45	13.73	5.02	4.52	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	100.10	199.65	21.25	85.56	2.80	0.56
bladder, adult, pool1	10011-101C2	15.64	42.59	1.85	0.87	0.87	0.11
blood, adult, pool1	10053-101G8	4.43	62.01	4.43	6.64	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	64.23	83.07	22.27	16.27	8.56	0.00
bone marrow, adult	10192-103E3	13.50	49.26	12.82	12.82	2.70	0.67
brain, adult, donor1	10084-102B3	3.08	59.45	2.05	3.08	0.00	0.00
brain, adult, pool1	10012-101C3	4.79	63.36	1.89	4.34	0.45	0.33
brain, fetal, pool1	10085-102B4	8.01	170.97	0.00	0.00	5.34	0.00
breast carcinoma cell line:MCF7	10482-107A5	78.30	111.00	6.28	8.92	6.28	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	116.21	82.63	11.61	12.36	5.12	0.25
breast, adult, donor1	10080-102A8	17.05	31.57	3.79	3.79	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	298.16	86.39	62.25	7.37	13.47	1.27
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	613.49	202.23	74.83	23.19	2.47	2.78
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	871.15	886.11	40.98	11.51	4.83	6.91
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	111.36	133.87	11.14	17.43	4.84	0.48
carcinoid cell line:NCI-H1770	10703-109H1	188.07	338.05	36.20	15.05	14.11	0.94
carcinoid cell line:NCI-H727	10735-110B6	355.27	240.42	16.19	13.24	8.86	1.75
carcinoid cell line:SK-PN-DW	10719-109I8	142.29	383.13	13.63	15.53	12.04	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	65.21	257.39	10.65	3.46	9.32	0.80
caudate nucleus - adult, donor10196	10177-103C6	10.36	47.20	2.30	5.76	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	8.03	57.06	2.01	3.01	0.84	0.17
caudate nucleus, adult, donor10258	10379-105H1	7.64	77.18	1.53	3.82	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	32.59	56.40	6.59	3.30	1.83	0.00
cerebellum - adult, donor10196	10173-103C2	8.74	96.14	0.00	5.83	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	13.45	81.13	1.71	3.63	1.28	0.21
cerebellum, adult, pool1	10083-102B2	6.21	50.02	1.03	3.45	0.69	0.00
cerebellum, newborn, donor10223	10357-105E6	16.61	31.55	5.81	9.96	0.83	0.00
cerebral meninges, adult	10188-103D8	2.27	43.87	1.01	2.27	0.76	0.00
cerebrospinal fluid, donor2	10294-104G6	21.93	27.04	6.58	5.85	1.46	0.00
cervical cancer cell line:D98-AH2	10552-107I3	96.19	158.45	15.82	26.02	46.59	0.29
cervical cancer cell line:ME-180	10553-107I4	118.32	104.90	18.89	10.11	5.97	0.17
cervix, adult, pool1	10013-101C4	24.36	34.86	1.68	2.94	0.73	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	24.24	45.84	5.02	2.23	0.42	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	22.21	39.19	6.53	2.61	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	1584.52	499.59	54.18	27.96	12.55	3.60
choriocarcinoma cell line:SCH	10785-110H2	668.67	146.25	23.04	7.39	6.04	1.72
choriocarcinoma cell line:T3M-3	10618-108G6	664.10	184.05	45.54	18.50	5.69	0.71
chorionic membrane cells, donor1	12238-129G6	12.82	24.79	0.85	1.42	0.28	0.57
chorionic membrane cells, donor2	12239-129G7	190.21	84.72	34.50	10.14	3.38	0.60
chorionic membrane cells, donor3	12240-129G8	10.44	27.47	0.55	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	195.90	169.65	123.20	17.17	4.04	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	488.12	377.09	38.04	22.67	7.30	1.54
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	178.03	229.56	36.75	38.44	8.45	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	843.33	1159.71	81.92	24.14	14.89	1.54
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	969.45	1294.77	73.29	27.09	16.45	4.60
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	1102.55	1153.45	104.04	22.60	10.59	7.33
chronic myelogenous leukemia cell line:K562	10454-106G4	884.84	1108.04	59.77	9.42	10.31	1.47
chronic myelogenous leukemia cell line:KU812	10409-106B4	492.32	710.99	61.25	38.83	6.26	1.82
clear cell carcinoma cell line:JHOC-5	10638-108I8	395.45	381.05	108.35	10.74	6.63	4.34
clear cell carcinoma cell line:TEN	10636-108I6	438.62	210.12	24.64	8.50	8.68	1.56
colon carcinoma cell line:CACO-2	10513-107D9	220.93	138.01	9.52	3.11	5.31	0.00
colon carcinoma cell line:COLO-320	10420-106C6	293.04	500.95	21.28	23.95	55.11	1.14
colon, adult, donor1	10082-102B1	60.69	115.43	5.95	2.38	2.38	0.00
colon, adult, pool1	10014-101C5	41.48	92.71	4.23	2.59	1.88	0.12
colon, fetal, donor1	10070-101I7	39.55	81.57	0.00	2.47	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	41.25	183.34	9.17	0.00	36.67	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	250.37	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	70.11	72.24	4.67	7.65	2.55	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	131.61	125.58	17.36	30.64	3.17	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	155.54	138.47	19.74	38.50	1.83	0.28
corpus callosum, adult, pool1	10042-101F6	9.62	30.29	3.98	5.20	1.11	0.22
cruciate ligament, donor2	10295-104G7	37.28	51.06	9.73	10.54	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	11.24	10.43	0.80	3.21	0.80	0.00
diencephalon, adult	10193-103E4	4.56	39.36	1.44	3.60	1.20	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	206.19	338.45	145.57	132.03	6.66	4.82
ductal cell carcinoma cell line:KLM-1	10438-106E6	370.30	280.03	45.65	30.00	26.41	1.03
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	855.77	237.35	157.43	18.29	9.63	0.48
ductus deferens, adult	10196-103E7	6.48	39.87	1.50	0.50	1.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	28.80	110.90	2.88	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	22.81	124.32	8.09	4.41	5.15	1.47
dura mater, adult, donor1	10041-101F5	12.47	37.33	4.21	24.45	1.82	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	62.85	95.94	62.85	14.43	1.55	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	114.49	144.87	51.87	17.91	2.29	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	1154.92	189.92	468.01	38.23	6.78	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	806.72	172.85	225.22	17.56	5.15	4.24
embryonic pancreas cell line:1C3IKEI	10606-108F3	1068.58	212.42	340.86	23.46	3.70	2.16
embryonic pancreas cell line:2C6	10603-108E9	1070.47	158.93	637.03	40.72	9.19	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	207.82	187.71	37.88	18.10	22.12	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	157.49	149.88	22.11	5.62	4.17	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	149.23	175.61	28.62	7.56	1.29	0.64
epidermoid carcinoma cell line:A431	10426-106D3	653.61	393.72	53.47	18.90	6.34	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	704.57	279.69	139.35	39.15	3.63	1.43
epididymis, adult	10197-103E8	10.88	31.40	0.63	1.88	2.09	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	91.90	97.58	12.60	2.48	0.89	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	37.75	53.48	7.08	3.54	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	326.18	158.83	68.54	20.97	5.24	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	359.92	162.29	57.48	26.08	7.58	1.67
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	369.92	175.33	81.45	29.91	6.95	2.13
esophagus, adult, pool1	10015-101C6	117.11	101.40	4.99	5.20	1.70	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	110.33	213.28	42.33	12.40	2.13	0.63
eye - muscle inferior rectus, donor1	10272-104E2	0.00	14.49	0.00	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	6.31	23.15	2.10	8.42	6.31	2.10
eye - muscle medial, donor2	10299-104H2	2.98	2.98	4.46	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	11.46	24.08	11.46	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	61.21	91.82	10.20	5.83	4.37	1.46
eye, fetal, donor1	10054-101G9	19.32	54.66	4.07	5.59	1.53	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	603.30	188.87	319.15	26.29	3.21	2.18
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	460.12	342.36	273.03	55.32	16.86	2.61
frontal lobe, adult, pool1	10040-101F4	5.44	75.53	1.78	6.47	1.03	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	72.96	74.76	18.01	4.80	10.81	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	607.41	378.18	226.67	22.58	8.78	1.46
gall bladder, adult	10198-103E9	36.21	59.88	3.86	1.45	1.93	0.00
gamma delta positive T cells, donor1	11937-126A2	11.27	98.78	4.29	4.29	2.15	0.00
gamma delta positive T cells, donor2	11938-126A3	7.10	70.22	1.87	5.98	0.75	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	17.74	26.19	9.50	1.69	1.69	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	419.52	353.76	32.49	15.47	3.48	1.16
gastric cancer cell line:AZ521	10549-107H9	758.46	434.81	297.09	32.30	10.66	0.98
gastric cancer cell line:GSS	10560-108A2	92.44	625.10	15.56	8.24	2.75	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	282.14	374.90	18.51	9.60	7.54	3.66
giant cell carcinoma cell line:LU65	10487-107B1	339.06	508.64	84.45	17.56	11.02	0.69
giant cell carcinoma cell line:Lu99B	10433-106E1	1680.35	411.06	297.97	12.60	12.32	2.80
glassy cell carcinoma cell line:HOKUG	10688-109F4	103.51	101.76	13.47	7.23	5.99	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	32.40	38.42	13.83	10.77	7.28	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	28.51	31.60	16.01	10.67	5.06	0.00
glioblastoma cell line:T98G	10485-107A8	31.79	76.16	37.53	26.82	9.60	0.00
glioma cell line:GI-1	10413-106B8	151.12	178.07	13.47	7.03	10.54	0.59
globus pallidus - adult, donor10196	10175-103C4	6.56	27.70	5.10	1.46	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	17.33	44.18	6.83	8.30	1.46	0.00
globus pallidus, adult, donor10258	10367-105F7	1.37	9.58	1.37	4.11	2.74	0.00
globus pallidus, newborn, donor10223	10364-105F4	37.84	36.24	13.86	3.73	1.07	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	24.47	107.67	17.13	51.39	46.50	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	229.50	32.79	43.71	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	146.34	5.23	88.85	10.45	0.00
granulosa cell tumor cell line:KGN	10624-108H3	135.36	141.12	20.48	7.36	5.44	0.96
hIPS +CCl2, biol_rep1	14383-156B9	342.04	892.98	28.01	14.69	4.59	5.51
hIPS +CCl2, biol_rep2	14384-156C1	251.04	910.87	28.81	13.72	9.60	10.52
hIPS +CCl2, biol_rep3	14385-156C2	188.08	754.23	30.92	10.31	10.31	3.86
hIPS, biol_rep1	14380-156B6	97.74	603.66	11.50	15.81	4.31	2.87
hIPS, biol_rep2	14381-156B7	130.31	593.28	17.15	8.92	2.74	6.86
hIPS, biol_rep3	14382-156B8	50.76	145.66	4.41	3.31	4.41	1.10
hairy cell leukemia cell line:Mo	10712-109I1	32.47	114.94	3.16	20.69	0.86	0.29
heart - mitral valve, adult	10205-103F7	4.48	12.26	0.60	2.39	0.90	0.30
heart - pulmonic valve, adult	10206-103F8	10.20	23.27	0.52	4.45	0.78	0.26
heart - tricuspid valve, adult	10207-103F9	5.83	9.16	2.50	1.67	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	61.01	104.27	9.39	3.26	1.84	0.61
heart, adult, diseased, donor1	10051-101G6	14.90	40.03	0.85	2.13	0.85	0.00
heart, adult, pool1	10016-101C7	23.92	40.02	2.53	5.75	2.07	0.00
heart, fetal, pool1	10046-101G1	34.71	53.39	4.31	6.57	1.03	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	15.43	43.50	7.10	2.78	2.47	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	727.78	397.18	23.78	5.95	15.46	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	434.58	323.64	38.89	11.49	9.94	2.65
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	422.14	319.94	37.99	11.05	9.10	2.67
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	474.65	364.60	34.26	13.04	14.55	2.83
hepatoma cell line:Li-7	10484-107A7	141.58	97.65	17.24	12.34	3.34	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	408.13	267.73	78.29	132.66	12.86	0.80
hippocampus - adult, donor10196	10169-103B7	1.89	36.91	2.84	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	10.82	50.00	4.29	5.10	1.84	0.20
hippocampus, adult, donor10258	10374-105G5	1.99	40.83	1.00	3.98	1.49	0.00
hippocampus, newborn, donor10223	10363-105F3	21.15	40.89	8.81	1.41	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	995.47	809.32	59.81	13.43	4.88	12.82
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	1194.82	759.70	67.94	9.82	5.11	3.14
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	1039.96	747.47	66.01	12.44	4.57	4.06
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	445.45	670.43	6.77	7.89	9.02	3.95
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	701.04	880.76	13.69	11.36	12.91	13.43
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	636.23	811.99	13.67	9.87	11.01	2.66
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	318.23	291.37	11.97	8.47	11.68	3.21
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	515.09	392.51	14.43	7.97	14.00	1.72
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	324.48	237.73	15.01	8.34	14.18	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	297.89	148.94	12.55	13.26	6.39	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	440.85	237.70	20.73	11.41	7.07	2.57
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	274.71	148.13	20.87	8.08	8.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	1326.05	745.18	74.64	10.95	7.04	7.82
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	1029.26	810.14	69.76	12.28	4.91	16.70
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	843.95	891.08	63.71	12.22	2.62	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	773.57	702.55	18.52	11.26	8.02	3.63
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	538.99	620.53	20.06	9.59	6.54	3.05
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	323.35	464.78	11.49	8.00	4.00	4.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	286.17	311.60	9.23	8.85	4.52	2.07
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	231.00	285.56	10.00	5.00	4.55	3.18
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	179.17	222.40	5.64	5.95	4.07	2.19
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	174.41	127.70	12.57	9.47	2.45	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	159.96	135.28	10.45	8.13	2.61	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	124.95	114.79	10.46	12.55	2.39	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	1293.03	668.41	67.80	9.61	3.88	5.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	1187.92	582.27	72.46	10.27	4.85	5.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	1177.16	684.74	68.60	8.57	4.90	9.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	572.84	498.90	18.66	8.10	7.75	11.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	582.80	484.61	18.69	6.33	6.65	5.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	582.24	494.78	24.21	9.68	5.14	3.93
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	208.40	188.75	9.31	6.72	7.24	2.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	192.61	174.01	10.63	6.64	3.32	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	216.51	188.81	8.98	13.60	5.13	1.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	174.61	133.96	18.92	10.74	5.11	2.56
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	130.24	129.49	8.33	15.14	3.03	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	159.63	115.60	14.79	9.75	4.03	2.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	1188.45	765.57	63.76	12.08	5.55	6.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	879.73	662.25	57.94	14.26	4.90	5.79
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	990.74	642.44	55.61	12.68	5.85	7.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	630.18	676.33	12.53	8.56	6.11	4.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	735.23	1216.71	22.77	22.77	3.25	16.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	625.15	742.63	22.84	12.91	7.61	4.96
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	318.53	336.59	14.78	9.85	8.76	2.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	314.48	271.05	9.41	10.13	10.49	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	254.80	263.70	10.68	6.76	6.41	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	153.95	199.30	16.71	8.35	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	275.46	186.89	19.09	16.79	4.88	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	158.94	116.11	11.85	9.97	2.16	1.62
immature langerhans cells, donor1	11904-125F5	20.34	99.04	3.39	12.83	0.73	0.00
immature langerhans cells, donor2	11905-125F6	33.27	69.71	7.13	13.47	3.17	0.00
insula, adult, pool1	10039-101F3	7.95	97.76	3.60	6.34	2.08	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	60.15	90.07	6.50	9.43	5.85	0.33
kidney, adult, pool1	10017-101C8	20.13	26.43	2.70	2.60	0.40	0.00
kidney, fetal, pool1	10045-101F9	62.39	83.04	4.74	4.17	2.26	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	694.77	253.51	1259.73	61.78	12.21	1.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	53.78	104.37	6.50	4.15	6.91	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	264.97	142.95	73.03	10.64	20.74	0.37
left atrium, adult, donor1	10079-102A7	8.17	34.87	1.63	1.09	0.54	0.00
left ventricle, adult, donor1	10078-102A6	11.63	26.80	1.52	1.01	2.02	0.00
leiomyoblastoma cell line:G-402	10721-110A1	85.91	178.12	18.06	9.03	2.46	0.00
leiomyoma cell line:10964C	10569-108B2	276.62	126.81	270.16	25.51	29.10	3.23
leiomyoma cell line:15242A	10570-108B3	102.72	66.30	91.85	16.85	13.04	2.72
leiomyoma cell line:15425	10571-108B4	380.49	147.87	346.26	34.97	32.78	2.43
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	0.00	12.70	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	142.20	169.38	153.70	43.91	15.68	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	245.44	576.36	30.81	21.84	2.36	0.83
liposarcoma cell line:KMLS-1	10782-110G8	16.25	34.83	4.22	2.19	2.19	0.00
liposarcoma cell line:SW 872	10726-110A6	171.31	80.05	157.66	35.94	7.55	0.49
liver, adult, pool1	10018-101C9	4.05	15.23	0.32	1.13	0.00	0.00
liver, fetal, pool1	10086-102B5	99.72	75.26	11.29	4.70	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	19.25	46.08	9.62	3.21	2.92	0.15
locus coeruleus, adult, donor10252	10165-103B3	12.36	34.88	3.14	3.69	1.85	0.00
locus coeruleus, adult, donor10258	10375-105G6	3.67	24.83	1.69	3.39	1.97	0.28
locus coeruleus, newborn, donor10223	10362-105F2	77.39	47.95	17.25	5.47	0.00	1.68
lung adenocarcinoma cell line:A549	10499-107C4	277.20	120.27	24.36	6.09	3.32	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	1231.97	426.05	213.03	48.26	25.51	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	2033.53	327.30	1110.29	38.49	15.29	8.96
lung, adult, pool1	10019-101D1	33.67	63.91	7.80	4.84	0.71	0.24
lung, fetal, donor1	10068-101I5	24.55	96.47	2.28	2.28	1.71	0.00
lung, right lower lobe, adult, donor1	10075-102A3	5.50	25.66	0.92	3.67	0.46	0.00
lymph node, adult, donor1	10077-102A5	19.88	79.05	6.15	8.05	0.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	76.27	146.19	35.29	85.48	1.10	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	174.02	261.86	178.55	206.62	6.19	1.81
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	196.23	206.43	35.68	23.79	7.65	0.00
mature adipocyte, donor1	12231-129F8	7.55	18.20	0.44	2.66	1.33	0.00
mature adipocyte, donor2	12232-129F9	10.17	20.96	2.08	0.62	1.25	0.00
mature adipocyte, donor3	12233-129G1	14.70	21.34	3.08	0.71	0.95	0.00
mature adipocyte, donor4	12234-129G2	9.48	23.95	1.05	2.37	1.32	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	109.84	284.96	5.24	13.34	4.77	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	7.90	66.55	5.64	4.51	2.26	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	10.11	65.84	1.29	3.68	1.47	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	3.18	56.23	1.27	4.13	0.95	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	14.50	48.19	3.41	8.53	2.13	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	11.31	108.17	5.06	4.22	1.86	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	10.61	60.27	2.97	5.31	1.27	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	5.78	48.16	1.93	1.93	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	114.83	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	16.87	53.84	7.18	5.38	2.51	0.00
medulla oblongata - adult, donor10196	10174-103C3	10.38	24.01	5.19	1.95	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	14.71	32.35	5.73	4.33	1.24	0.00
medulla oblongata, adult, pool1	10038-101F2	12.65	43.43	3.92	5.88	2.69	0.00
medulla oblongata, newborn, donor10223	10361-105F1	34.37	23.26	14.93	2.43	0.35	0.35
medulloblastoma cell line:D283 Med	10838-111E1	181.34	242.22	29.45	34.54	18.60	2.66
medulloblastoma cell line:ONS-76	10759-110E3	162.50	120.56	107.60	25.43	13.45	0.86
melanoma cell line:COLO 679	10514-107E1	48.59	53.76	27.02	12.07	4.60	0.00
melanoma cell line:G-361	10465-106H6	17.65	74.65	6.24	12.76	9.50	0.54
meningioma cell line:HKBMM	10691-109F7	989.73	83.76	1009.81	26.23	6.69	14.11
merkel cell carcinoma cell line:MKL-1	10843-111E6	281.09	389.47	138.34	34.37	44.94	3.52
merkel cell carcinoma cell line:MS-1	10844-111E7	158.13	136.09	63.51	23.33	11.67	1.30
mesenchymal precursor cell - adipose, donor1	11747-123G1	231.07	181.82	64.14	18.87	9.67	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	99.98	168.87	8.36	5.27	9.27	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	204.57	218.65	62.12	16.98	6.63	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	319.86	227.29	65.60	15.31	10.25	0.84
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	110.92	190.64	12.71	5.97	9.24	0.96
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	122.16	148.53	59.69	13.19	9.02	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	174.04	166.66	24.89	7.21	6.01	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	245.90	210.36	31.86	7.94	9.43	1.27
mesenchymal precursor cell - cardiac, donor3	11754-123G8	122.29	142.45	24.27	12.87	5.44	0.66
mesenchymal precursor cell - cardiac, donor4	11755-123G9	160.29	105.87	52.26	13.23	7.02	1.35
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	330.62	161.18	67.15	10.95	4.55	2.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	261.51	267.44	132.07	20.42	14.16	1.98
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	183.20	158.44	29.06	10.65	6.50	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	402.49	240.87	131.60	19.90	10.47	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	248.88	179.05	46.75	8.17	5.31	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	150.61	131.20	61.47	16.18	5.75	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	158.38	195.83	13.97	3.41	7.03	0.83
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	163.93	83.44	73.64	12.77	7.30	2.28
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	257.19	152.30	119.99	18.04	2.52	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	154.67	147.79	31.53	11.81	5.83	1.49
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	362.73	217.25	45.95	11.90	9.10	1.40
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	328.77	292.69	66.64	11.41	6.26	2.21
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	168.83	142.51	77.55	14.02	5.44	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	72.84	97.68	15.16	6.32	4.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	74.89	88.59	28.77	10.50	1.83	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	71.11	91.57	39.90	8.19	1.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	73.29	107.32	42.67	9.16	2.09	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	74.87	101.67	38.20	8.63	4.31	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	59.78	103.56	34.60	9.41	1.41	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	60.25	101.54	39.60	10.15	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	78.20	106.10	39.30	13.75	2.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	58.39	94.53	38.46	6.95	2.78	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	144.91	96.61	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	87.39	117.10	55.09	11.25	1.73	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	82.77	106.87	41.72	8.92	2.01	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	79.56	102.63	43.50	9.85	1.20	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	85.07	110.73	44.00	7.33	3.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	57.06	104.39	34.91	7.38	2.01	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	67.96	109.30	36.84	7.78	1.64	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	67.87	105.24	35.22	12.03	1.29	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	73.83	147.66	27.34	8.20	8.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	61.98	103.30	36.15	0.00	10.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	69.18	113.68	38.97	13.97	0.32	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	61.11	107.67	29.10	5.82	7.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	91.69	126.87	45.31	8.00	2.67	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	61.33	103.04	34.35	11.45	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	67.64	105.34	38.87	14.77	2.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	39.88	115.43	29.38	8.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	61.59	130.14	29.80	6.95	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	47.67	152.55	19.07	4.77	19.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	59.89	115.04	30.24	9.49	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	97.48	120.63	36.55	18.28	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	108.21	0.00	54.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	72.84	136.18	38.64	11.40	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	45.18	91.05	11.04	4.48	1.38	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	45.13	111.76	15.04	4.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	39.92	83.83	0.00	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	79.21	0.00	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	25.67	56.23	2.04	1.22	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	19.07	58.79	3.97	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	12.38	56.59	1.18	1.18	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	8.10	47.07	1.25	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	14.70	44.11	4.01	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	17.74	54.40	11.83	5.91	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	30.82	69.34	5.14	2.57	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	28.22	61.96	9.64	6.20	0.69	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	23.26	57.40	1.98	2.47	1.48	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	13.46	38.13	5.61	2.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	20.35	48.98	1.27	1.91	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	14.51	33.45	3.63	2.82	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	32.71	54.51	2.18	0.00	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	12.67	36.74	0.00	6.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	20.63	33.38	1.21	2.43	4.25	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	45.19	0.00	4.52	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	10.71	30.48	2.47	0.82	1.65	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	15.48	24.60	1.79	1.79	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	13.95	31.48	1.30	0.00	0.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	10.19	31.58	0.00	2.04	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	10.83	23.21	6.19	1.55	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	310.18	333.81	23.39	9.92	5.67	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	96.38	94.52	10.89	7.18	5.56	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	346.16	188.04	196.59	17.09	12.82	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	255.33	150.22	102.65	16.13	5.03	0.92
mesothelioma cell line:Mero-25	10850-111F4	337.71	237.39	125.05	30.18	7.72	1.82
mesothelioma cell line:Mero-41	10851-111F5	90.21	126.64	31.05	16.38	9.29	1.22
mesothelioma cell line:Mero-48a	10852-111F6	221.87	191.09	113.59	28.12	7.09	0.66
mesothelioma cell line:Mero-82	10853-111F7	457.81	169.25	293.82	28.65	13.93	3.15
mesothelioma cell line:Mero-83	10854-111F8	160.86	126.64	51.75	18.72	7.49	0.17
mesothelioma cell line:Mero-84	10855-111F9	112.23	208.54	11.88	6.57	11.88	0.51
mesothelioma cell line:Mero-95	10856-111G1	29.81	82.20	9.52	8.07	5.80	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	309.43	106.68	167.14	19.22	4.31	0.99
mesothelioma cell line:NCI-H226	10846-111E9	490.67	171.58	365.97	45.43	6.33	2.17
mesothelioma cell line:NCI-H2452	10848-111F2	298.60	173.73	91.22	31.60	16.40	1.54
mesothelioma cell line:NCI-H28	10845-111E8	21.88	81.43	3.31	4.33	4.33	0.51
mesothelioma cell line:No36	10857-111G2	122.98	145.16	23.49	15.98	4.57	0.98
mesothelioma cell line:ONE58	10858-111G3	478.23	228.68	213.78	21.41	23.03	1.63
migratory langerhans cells, donor1	11901-125F2	4.99	41.07	4.22	42.41	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	4.40	22.84	2.56	27.96	0.24	0.00
migratory langerhans cells, donor3	11903-125F4	3.05	41.10	2.33	26.92	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	42.12	99.25	21.22	6.53	2.94	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	302.86	232.07	87.53	14.62	3.60	2.97
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	2394.34	299.46	1485.58	63.12	27.87	4.84
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	39.77	56.71	7.23	6.47	3.43	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	312.67	327.64	53.04	80.94	11.46	0.18
myeloma cell line:PCM6	10474-106I6	6.33	18.58	3.16	10.48	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	538.74	203.93	93.85	13.19	6.09	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	176.92	168.29	208.30	41.58	2.16	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	331.60	232.65	13.37	4.57	1.67	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	238.57	245.11	12.72	4.41	2.65	0.44
nasal epithelial cells, donor2	12227-129F4	186.02	204.79	20.42	6.07	1.66	0.00
neuroblastoma cell line:CHP-134	10508-107D4	383.28	877.68	13.34	37.04	49.46	0.92
neuroblastoma cell line:NB-1	10539-107G8	24.13	121.23	19.27	14.59	7.30	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	32.48	149.31	12.44	26.99	6.33	1.27
neuroblastoma cell line:NH-12	10555-107I6	81.62	382.95	122.81	31.87	10.06	1.30
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	49.11	221.81	4.51	3.08	8.07	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	8.08	64.78	3.33	2.06	2.69	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	222.39	338.12	25.56	8.25	13.89	1.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	116.35	315.34	27.97	15.26	66.76	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	44.45	51.37	22.62	8.25	4.79	0.53
neutrophil PMN, donor1	12133-128D9	0.00	14.87	0.00	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	37.88	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	60.04	199.56	52.93	48.88	16.91	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	20.01	34.42	4.80	2.40	10.41	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	42.96	37.51	62.52	6.73	1.92	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	34.95	36.52	22.60	7.62	2.89	0.79
nucleus accumbens, adult, pool1	10037-101F1	8.25	80.90	1.69	5.62	1.59	0.28
occipital cortex - adult, donor10196	10172-103C1	4.12	70.05	2.06	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	13.69	61.19	4.29	5.64	1.07	0.00
occipital cortex, newborn, donor10223	10355-105E4	12.74	48.40	12.74	11.28	3.28	0.00
occipital lobe, adult, donor1	10076-102A4	3.67	60.35	0.79	5.51	0.52	0.00
occipital lobe, fetal, donor1	10073-102A1	8.15	178.08	0.86	2.15	0.43	1.29
occipital pole, adult, pool1	10036-101E9	6.94	82.15	1.66	6.07	1.73	0.32
olfactory region, adult	10195-103E6	3.25	43.56	1.34	4.01	1.34	0.57
optic nerve, donor1	10277-104E7	4.00	18.01	2.00	6.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	195.58	140.56	10.25	5.35	3.30	0.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	263.64	247.71	11.13	6.46	4.67	0.82
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	210.81	166.11	48.43	22.69	4.74	2.37
oral squamous cell carcinoma cell line:SAS	10544-107H4	1046.51	798.86	86.63	20.45	6.93	4.62
osteoclastoma cell line:Hs 706.T	10704-109H2	13.52	30.87	5.29	2.35	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	2442.35	611.06	2121.87	206.49	14.02	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	124.27	182.37	23.33	18.03	4.24	0.21
ovary, adult, pool1	10020-101D2	5.42	15.11	0.96	1.75	0.09	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	33.36	61.41	8.07	3.67	0.55	0.00
pancreas, adult, donor1	10049-101G4	10.35	57.38	0.00	0.00	1.88	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	1342.33	189.52	58.70	13.70	3.63	3.07
papillary adenocarcinoma cell line:8505C	10437-106E5	219.41	119.25	392.83	46.68	8.18	2.90
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	1645.06	197.21	258.14	16.89	5.13	3.15
paracentral gyrus, adult, pool1	10035-101E8	6.13	73.13	2.01	4.48	1.56	0.09
parietal cortex, adult, donor10258	10373-105G4	9.54	82.21	2.20	5.14	0.73	0.73
parietal lobe - adult, donor10196	10171-103B9	7.52	48.91	4.70	1.88	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	6.84	67.55	2.85	1.71	1.14	0.00
parietal lobe, adult, pool1	10034-101E7	6.34	65.74	1.59	6.17	1.94	0.09
parietal lobe, fetal, donor1	10072-101I9	13.58	189.12	3.88	0.97	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	17.20	64.68	11.59	8.60	2.24	0.37
parotid gland, adult	10199-103F1	14.18	63.52	1.85	3.08	0.00	0.00
penis, adult	10200-103F2	15.58	30.08	2.69	0.54	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	27.15	202.30	2.05	1.67	2.79	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	166.53	98.34	51.72	15.30	4.66	0.58
pineal gland - adult, donor10196	10179-103C8	9.03	30.32	2.58	6.45	1.94	0.00
pineal gland, adult, donor10252	10160-103A7	22.50	65.14	1.78	4.74	1.78	0.00
pineal gland, adult, donor10258	10377-105G8	8.78	33.86	1.88	8.78	1.88	0.63
pituitary gland - adult, donor10196	10180-103C9	7.08	23.27	0.00	1.01	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	2.08	34.92	0.00	1.56	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	1.70	17.02	0.85	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	95.03	53.21	9.14	8.17	3.23	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	100.51	289.62	49.00	90.98	4.11	2.38
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	88.09	107.39	20.08	7.16	7.47	0.16
pons, adult, pool1	10033-101E6	12.22	57.67	2.58	6.54	1.20	0.09
postcentral gyrus, adult, pool1	10032-101E5	6.54	88.74	2.27	6.28	1.13	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	18.82	167.31	0.00	2.09	33.46	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	170.75	0.00	11.02	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	58.68	140.83	23.47	35.21	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	242.38	203.64	43.55	10.63	8.74	0.58
prostate cancer cell line:PC-3	10439-106E7	964.50	142.84	764.67	47.73	22.32	1.63
prostate, adult, pool1	10022-101D4	8.16	30.65	2.00	1.36	0.63	0.00
putamen, adult, donor10196	10176-103C5	9.68	80.26	4.72	2.60	0.94	0.24
putamen, adult, donor10252	10152-102I8	3.92	35.29	1.96	3.92	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	119.12	262.27	2.19	6.56	1.09	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	4.11	82.63	2.66	2.90	0.72	0.24
putamen, newborn, donor10223	10365-105F5	60.72	65.97	6.75	3.00	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	825.96	332.25	27.35	6.98	8.15	0.87
rectum, fetal, donor1	10067-101I4	22.26	70.94	1.39	2.78	1.39	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	18.44	44.52	4.03	4.66	0.85	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	20.71	128.82	5.38	1.66	4.56	0.00
retina, adult, pool1	10030-101E3	15.11	48.21	3.08	7.26	3.08	0.00
retinoblastoma cell line:Y79	10475-106I7	963.61	808.50	55.60	41.83	28.84	3.38
rhabdomyosarcoma cell line:KYM-1	10787-110H4	95.16	77.46	8.85	5.66	2.34	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	276.42	308.48	61.58	39.93	9.84	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	225.84	138.69	95.49	10.61	2.27	0.00
salivary acinar cells, donor1	11771-123I7	23.79	79.15	2.43	2.91	1.46	0.81
salivary acinar cells, donor2	11772-123I8	3.03	47.78	0.00	1.24	0.41	0.14
salivary acinar cells, donor3	11773-123I9	16.55	49.65	0.00	0.66	1.32	0.00
salivary gland, adult, pool1	10093-102C3	7.44	73.21	4.00	2.86	1.72	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	847.25	379.82	207.41	31.11	18.30	1.26
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	823.22	325.62	185.50	28.80	17.99	1.53
seminal vesicle, adult	10201-103F3	5.82	34.39	1.59	1.59	2.65	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	136.28	86.97	39.84	7.77	6.32	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	169.60	146.20	45.80	12.33	2.26	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	336.18	150.53	234.83	27.10	4.01	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	75.22	175.83	4.30	3.90	2.28	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	487.54	216.86	125.01	22.88	14.15	0.88
signet ring carcinoma cell line:NUGC-4	10483-107A6	535.20	162.70	117.41	17.55	10.32	1.68
skeletal muscle - soleus muscle, donor1	10282-104F3	34.05	11.35	3.55	2.84	1.42	0.71
skeletal muscle, adult, pool1	10023-101D5	74.36	35.86	5.88	7.20	1.68	0.24
skeletal muscle, fetal, donor1	10066-101I3	79.40	54.27	13.07	6.03	2.01	0.00
skin, adult, donor1	10074-102A2	20.36	74.64	0.00	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	37.87	80.17	4.42	0.63	2.52	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	96.39	57.70	28.02	7.00	5.67	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	39.40	159.49	10.09	6.30	6.93	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	18.70	124.51	5.40	5.59	10.22	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	142.91	133.02	55.71	40.71	19.45	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	248.51	706.77	53.08	24.61	14.64	3.54
small cell lung carcinoma cell line:WA-hT	10562-108A4	67.77	64.94	45.76	16.13	10.46	0.22
small intestine, adult, pool1	10024-101D6	74.17	148.35	6.81	2.75	3.58	0.12
small intestine, fetal, donor1	10064-101I1	66.09	139.56	5.41	4.18	1.72	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	75.40	190.80	13.34	8.21	8.72	1.54
smooth muscle, adult, pool1	10048-101G3	1.29	6.46	0.26	0.26	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	26.00	128.11	4.29	10.45	8.58	0.00
spinal cord - adult, donor10196	10181-103D1	8.72	30.05	3.67	2.98	1.61	0.00
spinal cord, adult, donor10252	10159-103A6	23.66	37.85	3.55	4.34	1.58	0.00
spinal cord, adult, donor10258	10369-105F9	0.00	17.99	0.00	2.08	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	11.59	53.67	4.27	6.71	3.05	0.00
spinal cord, newborn, donor10223	10359-105E8	27.55	34.90	11.48	7.35	0.92	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	156.52	89.31	102.46	18.07	7.32	1.05
spleen, adult, pool1	10025-101D7	54.85	76.98	19.05	19.60	0.33	0.22
spleen, fetal, pool1	10044-101F8	98.44	134.91	14.62	15.97	0.87	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	34.99	79.29	25.46	60.97	1.35	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	130.63	127.60	13.29	4.75	2.66	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	101.34	235.88	8.04	3.84	1.40	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	587.18	186.87	212.28	9.38	3.91	3.52
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	432.34	162.87	169.85	27.24	6.30	1.01
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	543.48	323.21	34.74	8.47	6.35	5.08
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	397.69	347.34	105.77	29.61	7.62	1.69
stomach, fetal, donor1	10062-101H8	73.69	113.21	16.02	5.34	2.14	0.00
submaxillary gland, adult	10202-103F4	13.10	58.11	3.42	1.71	3.42	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	54.27
substantia nigra, adult, donor10252	10158-103A5	12.05	28.04	3.95	3.32	1.25	0.21
substantia nigra, adult, donor10258	10371-105G2	2.07	38.28	0.52	1.55	1.03	0.52
substantia nigra, newborn, donor10223	10358-105E7	21.20	28.97	13.42	4.24	0.71	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	11.46	56.17	5.50	10.78	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	7.38	93.42	2.46	5.93	1.36	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	8.55	191.60	2.14	8.55	2.14	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	26.81	199.11	8.35	4.40	1.76	0.88
tenocyte, donor1	11763-123H8	51.67	81.34	17.46	5.93	3.14	1.05
tenocyte, donor2	11765-123I1	15.26	34.34	8.77	0.76	1.14	0.00
tenocyte, donor3	11768-123I4	74.50	74.87	46.70	7.41	5.93	1.48
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	816.83	481.16	94.16	22.77	24.30	1.53
teratocarcinoma cell line:NCR-G1	10798-110I6	325.56	237.39	9.40	3.24	5.40	0.92
teratocarcinoma cell line:PA-1	10807-111A6	1130.25	526.15	151.88	12.55	4.18	3.25
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	1143.03	442.54	77.82	10.66	2.54	3.05
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	1437.81	1402.26	48.78	12.86	4.54	5.67
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	3033.90	958.99	54.75	8.83	4.91	10.58
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	954.31	414.62	111.39	17.26	6.51	7.82
testis, adult, pool1	10026-101D8	41.88	87.29	8.27	10.20	4.94	0.43
testis, adult, pool2	10096-102C6	78.04	176.83	23.01	23.01	9.47	2.71
thalamus - adult, donor10196	10168-103B6	8.83	40.85	5.52	3.31	2.21	0.00
thalamus, adult, donor10252	10154-103A1	14.85	32.04	5.31	4.22	0.94	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	1.54	32.33	3.08	4.62	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	3.29	20.59	0.99	2.14	0.66	0.00
thalamus, newborn, donor10223	10366-105F6	31.07	26.46	7.48	5.75	1.15	0.58
throat, adult	10209-103G2	73.65	81.64	3.99	3.50	2.75	0.50
throat, fetal, donor1	10061-101H7	44.49	46.92	3.05	1.52	2.44	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	72.14	422.50	12.72	12.32	35.97	0.79
thymus, adult, pool1	10027-101D9	295.66	322.40	13.42	9.35	6.36	0.70
thymus, fetal, pool1	10043-101F7	329.17	280.02	14.34	9.56	8.52	0.94
thyroid carcinoma cell line:KHM-5M	10776-110G2	880.73	238.93	739.00	53.45	8.51	4.92
thyroid carcinoma cell line:TCO-1	10783-110G9	705.58	322.69	580.41	32.27	14.67	3.77
thyroid, adult, pool1	10028-101E1	21.28	57.39	1.77	1.12	0.65	0.09
thyroid, fetal, donor1	10060-101H6	20.57	37.18	1.05	0.79	2.11	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	21.56	36.96	3.08	6.16	3.08	0.00
tongue, adult	10203-103F5	74.19	109.31	5.35	6.05	1.63	1.40
tongue, fetal, donor1	10059-101H5	43.35	51.63	3.55	5.12	2.76	0.00
tonsil, adult, pool1	10047-101G2	207.96	231.81	25.34	29.05	3.21	0.50
trachea, adult, pool1	10029-101E2	67.07	84.01	6.87	3.76	1.64	0.25
trachea, fetal, donor1	10058-101H4	25.39	37.32	4.62	0.38	1.54	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	350.73	160.49	442.84	39.32	6.73	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	363.73	140.12	116.62	21.68	9.42	0.61
transitional-cell carcinoma cell line:JMSU1	10492-107B6	665.14	293.63	261.67	15.20	8.15	1.25
tridermal teratoma cell line:HGRT	10694-109G1	363.38	91.32	235.91	22.83	11.42	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	1383.70	188.86	1479.86	46.22	18.12	2.96
umbilical cord, fetal, donor1	10057-101H3	18.78	56.34	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	5.46	26.45	1.54	1.37	0.85	0.00
uterus, fetal, donor1	10055-101H1	24.57	35.32	1.02	1.54	1.02	0.00
vagina, adult	10204-103F6	5.82	36.83	0.65	1.29	0.00	0.00
vein, adult	10191-103E2	33.32	79.57	10.30	7.89	1.97	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	122.30	275.31	57.15	84.65	2.14	0.27

Property "Nearest transcripts" (as page type) with input value "M23614:-35 M23615:-35 AF176039:114 BC067083:-242 BC071863:-244 BC071864:-262 BC004924:-267 BC008963:-267 BC008832:-267 BC063434:-273 AK308245:-284 X14957:-296 X14958:-296 AK301434:-313 ENST00000674029.1:-314 ENST00000447654.5:-314 ENST00000347617.10:-314 ENST00000401473.7:-314 ENST00000311487.9:-314 NM_001319081.2:-314 NM_001319077.2:-314 NM_001319079.2:-314 NM_145903.3:-314 NM_001319078.2:-314 NM_002131.4:-314 NM_001319080.2:-314 NM_145899.3:-314 NM_001319082.2:-314 NM_145902.3:-314 NM_145901.3:-314 AK096863:-314 M23616:-314 M23617:-314 LQ270834:-314 LQ270836:-314 LF213809:-354 MA449386:-354 LQ270830:-387 LQ270832:-387 LQ270838:-387 M23619:432" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.